JP2008520738A5

JP2008520738A5 -

Download PDF

Info

Publication number: JP2008520738A5
Authority: JP; Japan
Prior art keywords: aliphatic; optionally substituted; compound according; membered; compound
Prior art date: 2005-11-22
Legal status : Pending

Application number

JP2007543441A

Other languages

English (en)

Japanese (ja)

Other versions

JP2008520738A (ja

Filing date

2005-11-22

Publication date

2008-11-06

2005-11-22 Application filed filed Critical

2005-11-22 Priority claimed from PCT/US2005/042455 external-priority patent/WO2006058074A1/en

2008-06-19 Publication of JP2008520738A publication Critical patent/JP2008520738A/ja

2008-11-06 Publication of JP2008520738A5 publication Critical patent/JP2008520738A5/ja

Status Pending legal-status Critical Current

Links

150000001875 compounds Chemical class 0.000 claims description 147
125000001931 aliphatic group Chemical group 0.000 claims description 75
-1 substituted —O Chemical class 0.000 claims description 67
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 52
239000000203 mixture Substances 0.000 claims description 51
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 39
125000003118 aryl group Chemical group 0.000 claims description 30
125000000623 heterocyclic group Chemical group 0.000 claims description 30
229910052757 nitrogen Inorganic materials 0.000 claims description 28
238000000034 method Methods 0.000 claims description 26
150000003839 salts Chemical class 0.000 claims description 26
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 24
125000001072 heteroaryl group Chemical group 0.000 claims description 23
125000005842 heteroatom Chemical group 0.000 claims description 23
125000001424 substituent group Chemical group 0.000 claims description 22
125000004429 atom Chemical group 0.000 claims description 20
229910052736 halogen Inorganic materials 0.000 claims description 19
150000002367 halogens Chemical class 0.000 claims description 19
125000000217 alkyl group Chemical group 0.000 claims description 17
206010028980 Neoplasm Diseases 0.000 claims description 16
NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims description 16
QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 16
239000005441 aurora Substances 0.000 claims description 16
125000002950 monocyclic group Chemical group 0.000 claims description 16
229910052760 oxygen Inorganic materials 0.000 claims description 16
239000001301 oxygen Substances 0.000 claims description 16
229920006395 saturated elastomer Polymers 0.000 claims description 16
229910052717 sulfur Inorganic materials 0.000 claims description 16
239000011593 sulfur Substances 0.000 claims description 16
102000001253 Protein Kinase Human genes 0.000 claims description 14
208000035475 disorder Diseases 0.000 claims description 14
229910052739 hydrogen Inorganic materials 0.000 claims description 14
125000000325 methylidene group Chemical group [H]C([H])=* 0.000 claims description 14
108060006633 protein kinase Proteins 0.000 claims description 14
201000011510 cancer Diseases 0.000 claims description 12
125000002619 bicyclic group Chemical group 0.000 claims description 11
239000001257 hydrogen Substances 0.000 claims description 11
125000006570 (C5-C6) heteroaryl group Chemical group 0.000 claims description 10
125000004093 cyano group Chemical group *C#N 0.000 claims description 10
125000004122 cyclic group Chemical group 0.000 claims description 9
230000000694 effects Effects 0.000 claims description 9
125000005843 halogen group Chemical group 0.000 claims description 9
125000003545 alkoxy group Chemical group 0.000 claims description 7
239000003937 drug carrier Substances 0.000 claims description 6
230000002401 inhibitory effect Effects 0.000 claims description 5
230000002062 proliferating effect Effects 0.000 claims description 5
125000006708 (C5-C14) heteroaryl group Chemical group 0.000 claims description 4
102100032306 Aurora kinase B Human genes 0.000 claims description 4
206010006187 Breast cancer Diseases 0.000 claims description 4
208000026310 Breast neoplasm Diseases 0.000 claims description 4
101000798306 Homo sapiens Aurora kinase B Proteins 0.000 claims description 4
125000003710 aryl alkyl group Chemical group 0.000 claims description 4
229910002091 carbon monoxide Inorganic materials 0.000 claims description 4
230000005764 inhibitory process Effects 0.000 claims description 4
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 3
239000002671 adjuvant Substances 0.000 claims description 3
125000006615 aromatic heterocyclic group Chemical group 0.000 claims description 3
229910052799 carbon Inorganic materials 0.000 claims description 3
210000003169 central nervous system Anatomy 0.000 claims description 3
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 3
125000001622 2-naphthyl group Chemical group [H]C1=C([H])C([H])=C2C([H])=C(*)C([H])=C([H])C2=C1[H] 0.000 claims description 2
206010005003 Bladder cancer Diseases 0.000 claims description 2
206010009944 Colon cancer Diseases 0.000 claims description 2
206010058467 Lung neoplasm malignant Diseases 0.000 claims description 2
206010033128 Ovarian cancer Diseases 0.000 claims description 2
206010061535 Ovarian neoplasm Diseases 0.000 claims description 2
206010035226 Plasma cell myeloma Diseases 0.000 claims description 2
206010038389 Renal cancer Diseases 0.000 claims description 2
208000005718 Stomach Neoplasms Diseases 0.000 claims description 2
208000029742 colonic neoplasm Diseases 0.000 claims description 2
206010017758 gastric cancer Diseases 0.000 claims description 2
208000032839 leukemia Diseases 0.000 claims description 2
201000005202 lung cancer Diseases 0.000 claims description 2
208000020816 lung neoplasm Diseases 0.000 claims description 2
201000001441 melanoma Diseases 0.000 claims description 2
201000000050 myeloid neoplasm Diseases 0.000 claims description 2
201000011549 stomach cancer Diseases 0.000 claims description 2
239000003981 vehicle Substances 0.000 claims description 2
125000004435 hydrogen atom Chemical class [H]* 0.000 claims 4
150000001721 carbon Chemical class 0.000 claims 3
239000012472 biological sample Substances 0.000 claims 2
206010008342 Cervix carcinoma Diseases 0.000 claims 1
208000008839 Kidney Neoplasms Diseases 0.000 claims 1
206010025323 Lymphomas Diseases 0.000 claims 1
206010029260 Neuroblastoma Diseases 0.000 claims 1
206010061902 Pancreatic neoplasm Diseases 0.000 claims 1
206010060862 Prostate cancer Diseases 0.000 claims 1
208000000236 Prostatic Neoplasms Diseases 0.000 claims 1
208000007097 Urinary Bladder Neoplasms Diseases 0.000 claims 1
208000006105 Uterine Cervical Neoplasms Diseases 0.000 claims 1
125000005605 benzo group Chemical group 0.000 claims 1
201000010881 cervical cancer Diseases 0.000 claims 1
150000001805 chlorine compounds Chemical class 0.000 claims 1
201000010982 kidney cancer Diseases 0.000 claims 1
208000015486 malignant pancreatic neoplasm Diseases 0.000 claims 1
230000011278 mitosis Effects 0.000 claims 1
229910017464 nitrogen compound Inorganic materials 0.000 claims 1
150000002830 nitrogen compounds Chemical class 0.000 claims 1
201000002528 pancreatic cancer Diseases 0.000 claims 1
208000008443 pancreatic carcinoma Diseases 0.000 claims 1
201000005112 urinary bladder cancer Diseases 0.000 claims 1
0 C*=C=*C(C(c1nc(C)c(*)nc1*)=*)=C Chemical compound C*=C=*C(C(c1nc(C)c(*)nc1*)=*)=C 0.000 description 43
235000002639 sodium chloride Nutrition 0.000 description 33
201000010099 disease Diseases 0.000 description 25
YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 23
239000000243 solution Substances 0.000 description 21
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 20
XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 20
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 18
239000003112 inhibitor Substances 0.000 description 18
ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 16
238000006243 chemical reaction Methods 0.000 description 16
239000011541 reaction mixture Substances 0.000 description 15
WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 14
239000008194 pharmaceutical composition Substances 0.000 description 14
239000003153 chemical reaction reagent Substances 0.000 description 13
239000003814 drug Substances 0.000 description 13
IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 12
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 12
YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 12
239000000543 intermediate Substances 0.000 description 12
KDLHZDBZIXYQEI-UHFFFAOYSA-N palladium Substances [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 11
230000001404 mediated effect Effects 0.000 description 10
JYAUQLBWOPEZFN-UHFFFAOYSA-N 2-chloro-7-iodo-5h-pyrrolo[2,3-b]pyrazine Chemical compound ClC1=CN=C2NC=C(I)C2=N1 JYAUQLBWOPEZFN-UHFFFAOYSA-N 0.000 description 9
DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 9
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 9
239000000725 suspension Substances 0.000 description 9
SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 8
OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 8
NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 8
239000002552 dosage form Substances 0.000 description 8
229940079593 drug Drugs 0.000 description 8
235000019439 ethyl acetate Nutrition 0.000 description 8
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
RORAIVYFQFAIAF-UHFFFAOYSA-N 2-chloro-5h-pyrrolo[2,3-b]pyrazine Chemical compound ClC1=CN=C2NC=CC2=N1 RORAIVYFQFAIAF-UHFFFAOYSA-N 0.000 description 7
MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 7
238000003556 assay Methods 0.000 description 7
238000005160 1H NMR spectroscopy Methods 0.000 description 6
ACFBUXHJONGLLF-UHFFFAOYSA-N 3-bromo-5-chloropyrazin-2-amine Chemical compound NC1=NC=C(Cl)N=C1Br ACFBUXHJONGLLF-UHFFFAOYSA-N 0.000 description 6
WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 6
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 6
PCLIMKBDDGJMGD-UHFFFAOYSA-N N-bromosuccinimide Chemical compound BrN1C(=O)CCC1=O PCLIMKBDDGJMGD-UHFFFAOYSA-N 0.000 description 6
239000002253 acid Substances 0.000 description 6
229920001223 polyethylene glycol Polymers 0.000 description 6
239000007787 solid Substances 0.000 description 6
239000002904 solvent Substances 0.000 description 6
HWCKAMAVEWVBDO-UHFFFAOYSA-N 5-chloropyrazin-2-amine Chemical compound NC1=CN=C(Cl)C=N1 HWCKAMAVEWVBDO-UHFFFAOYSA-N 0.000 description 5
102000004190 Enzymes Human genes 0.000 description 5
108090000790 Enzymes Proteins 0.000 description 5
LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 5
101150003085 Pdcl gene Proteins 0.000 description 5
239000002202 Polyethylene glycol Substances 0.000 description 5
239000003054 catalyst Substances 0.000 description 5
229940088598 enzyme Drugs 0.000 description 5
239000007788 liquid Substances 0.000 description 5
231100000252 nontoxic Toxicity 0.000 description 5
230000003000 nontoxic effect Effects 0.000 description 5
239000003921 oil Substances 0.000 description 5
235000019198 oils Nutrition 0.000 description 5
238000002360 preparation method Methods 0.000 description 5
125000006239 protecting group Chemical group 0.000 description 5
238000007363 ring formation reaction Methods 0.000 description 5
239000011780 sodium chloride Substances 0.000 description 5
239000000758 substrate Substances 0.000 description 5
238000012360 testing method Methods 0.000 description 5
FWSPXZXVNVQHIF-UHFFFAOYSA-N triethyl(ethynyl)silane Chemical group CC[Si](CC)(CC)C#C FWSPXZXVNVQHIF-UHFFFAOYSA-N 0.000 description 5
UJULUXSKCYVDPH-UHFFFAOYSA-N 2-chloro-7-iodo-5-(4-methylphenyl)sulfonylpyrrolo[2,3-b]pyrazine Chemical compound C1=CC(C)=CC=C1S(=O)(=O)N1C2=NC=C(Cl)N=C2C(I)=C1 UJULUXSKCYVDPH-UHFFFAOYSA-N 0.000 description 4
YYROPELSRYBVMQ-UHFFFAOYSA-N 4-toluenesulfonyl chloride Chemical compound CC1=CC=C(S(Cl)(=O)=O)C=C1 YYROPELSRYBVMQ-UHFFFAOYSA-N 0.000 description 4
FINYSTMVBSORBU-UHFFFAOYSA-N 5-chloro-3-(2-triethylsilylethynyl)pyrazin-2-amine Chemical compound CC[Si](CC)(CC)C#CC1=NC(Cl)=CN=C1N FINYSTMVBSORBU-UHFFFAOYSA-N 0.000 description 4
YWJRMNPASJCXSD-UHFFFAOYSA-N 7-(3-bromophenyl)-2-chloro-5h-pyrrolo[2,3-b]pyrazine Chemical compound C12=NC(Cl)=CN=C2NC=C1C1=CC=CC(Br)=C1 YWJRMNPASJCXSD-UHFFFAOYSA-N 0.000 description 4
QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 4
208000023275 Autoimmune disease Diseases 0.000 description 4
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 4
IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 4
JRNVZBWKYDBUCA-UHFFFAOYSA-N N-chlorosuccinimide Chemical compound ClN1C(=O)CCC1=O JRNVZBWKYDBUCA-UHFFFAOYSA-N 0.000 description 4
229910019142 PO4 Inorganic materials 0.000 description 4
OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical group [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 4
JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
229910000147 aluminium phosphate Inorganic materials 0.000 description 4
239000012267 brine Substances 0.000 description 4
239000000969 carrier Substances 0.000 description 4
125000000753 cycloalkyl group Chemical group 0.000 description 4
239000002270 dispersing agent Substances 0.000 description 4
239000003995 emulsifying agent Substances 0.000 description 4
150000002148 esters Chemical class 0.000 description 4
238000004128 high performance liquid chromatography Methods 0.000 description 4
150000002431 hydrogen Chemical class 0.000 description 4
208000027866 inflammatory disease Diseases 0.000 description 4
229940043355 kinase inhibitor Drugs 0.000 description 4
HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
239000002207 metabolite Substances 0.000 description 4
QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 4
239000012038 nucleophile Substances 0.000 description 4
210000000056 organ Anatomy 0.000 description 4
229910052763 palladium Inorganic materials 0.000 description 4
235000021317 phosphate Nutrition 0.000 description 4
229910052698 phosphorus Inorganic materials 0.000 description 4
239000011574 phosphorus Chemical group 0.000 description 4
239000000651 prodrug Substances 0.000 description 4
229940002612 prodrug Drugs 0.000 description 4
239000003909 protein kinase inhibitor Substances 0.000 description 4
238000010992 reflux Methods 0.000 description 4
HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 4
241000894007 species Species 0.000 description 4
229940124597 therapeutic agent Drugs 0.000 description 4
230000000699 topical effect Effects 0.000 description 4
238000011282 treatment Methods 0.000 description 4
WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
108090000433 Aurora kinases Proteins 0.000 description 3
102000003989 Aurora kinases Human genes 0.000 description 3
208000020084 Bone disease Diseases 0.000 description 3
229920002261 Corn starch Polymers 0.000 description 3
VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 3
108091000080 Phosphotransferase Proteins 0.000 description 3
OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 3
VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical group [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 3
238000006069 Suzuki reaction reaction Methods 0.000 description 3
ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
125000003342 alkenyl group Chemical group 0.000 description 3
239000012131 assay buffer Substances 0.000 description 3
230000015572 biosynthetic process Effects 0.000 description 3
239000001768 carboxy methyl cellulose Substances 0.000 description 3
210000004027 cell Anatomy 0.000 description 3
239000003795 chemical substances by application Substances 0.000 description 3
239000000460 chlorine Substances 0.000 description 3
KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
239000008120 corn starch Substances 0.000 description 3
206010012601 diabetes mellitus Diseases 0.000 description 3
235000014113 dietary fatty acids Nutrition 0.000 description 3
239000003085 diluting agent Substances 0.000 description 3
239000003480 eluent Substances 0.000 description 3
235000019441 ethanol Nutrition 0.000 description 3
239000000194 fatty acid Substances 0.000 description 3
229930195729 fatty acid Natural products 0.000 description 3
239000000796 flavoring agent Substances 0.000 description 3
238000009472 formulation Methods 0.000 description 3
208000019622 heart disease Diseases 0.000 description 3
229930195733 hydrocarbon Natural products 0.000 description 3
150000002430 hydrocarbons Chemical group 0.000 description 3
238000002347 injection Methods 0.000 description 3
239000007924 injection Substances 0.000 description 3
208000028867 ischemia Diseases 0.000 description 3
239000008101 lactose Substances 0.000 description 3
229910052943 magnesium sulfate Inorganic materials 0.000 description 3
235000019341 magnesium sulphate Nutrition 0.000 description 3
230000004770 neurodegeneration Effects 0.000 description 3
208000015122 neurodegenerative disease Diseases 0.000 description 3
239000004006 olive oil Substances 0.000 description 3
235000008390 olive oil Nutrition 0.000 description 3
230000007170 pathology Effects 0.000 description 3
235000019271 petrolatum Nutrition 0.000 description 3
239000000546 pharmaceutical excipient Substances 0.000 description 3
102000020233 phosphotransferase Human genes 0.000 description 3
125000000587 piperidin-1-yl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 3
239000003755 preservative agent Substances 0.000 description 3
108090000765 processed proteins & peptides Proteins 0.000 description 3
229960004063 propylene glycol Drugs 0.000 description 3
102000004169 proteins and genes Human genes 0.000 description 3
108090000623 proteins and genes Proteins 0.000 description 3
229910052710 silicon Chemical group 0.000 description 3
239000010703 silicon Chemical group 0.000 description 3
239000011734 sodium Substances 0.000 description 3
210000002784 stomach Anatomy 0.000 description 3
125000002088 tosyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1C([H])([H])[H])S(*)(=O)=O 0.000 description 3
VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 3
230000003612 virological effect Effects 0.000 description 3
239000001993 wax Substances 0.000 description 3
PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
KZPYGQFFRCFCPP-UHFFFAOYSA-N 1,1'-bis(diphenylphosphino)ferrocene Chemical compound [Fe+2].C1=CC=C[C-]1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=C[C-]1P(C=1C=CC=CC=1)C1=CC=CC=C1 KZPYGQFFRCFCPP-UHFFFAOYSA-N 0.000 description 2
JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 2
208000036762 Acute promyelocytic leukaemia Diseases 0.000 description 2
208000010507 Adenocarcinoma of Lung Diseases 0.000 description 2
208000024827 Alzheimer disease Diseases 0.000 description 2
QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 2
208000032791 BCR-ABL1 positive chronic myelogenous leukemia Diseases 0.000 description 2
NJQUYJVNPAXGBY-UHFFFAOYSA-N COc1ccc(CNc2nc(-c(c3n4)c[nH]c3ncc4Cl)ccc2)cc1 Chemical compound COc1ccc(CNc2nc(-c(c3n4)c[nH]c3ncc4Cl)ccc2)cc1 NJQUYJVNPAXGBY-UHFFFAOYSA-N 0.000 description 2
239000004215 Carbon black (E152) Substances 0.000 description 2
208000010833 Chronic myeloid leukaemia Diseases 0.000 description 2
UAUCUVKIISYPHH-UHFFFAOYSA-N Clc(nc12)cnc1[nH]cc2-c1cccc(NC2CCCCCC2)n1 Chemical compound Clc(nc12)cnc1[nH]cc2-c1cccc(NC2CCCCCC2)n1 UAUCUVKIISYPHH-UHFFFAOYSA-N 0.000 description 2
229910021595 Copper(I) iodide Inorganic materials 0.000 description 2
FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 2
MFRZJFJGPGCDJY-UHFFFAOYSA-N Fc(c(NCC1CCCCC1)c1)ccc1-c(c1n2)c[nH]c1ncc2Cl Chemical compound Fc(c(NCC1CCCCC1)c1)ccc1-c(c1n2)c[nH]c1ncc2Cl MFRZJFJGPGCDJY-UHFFFAOYSA-N 0.000 description 2
HVWQGCOUJLQMPD-UHFFFAOYSA-N Fc1ccc(C2(CC2)Nc2cc(-c(c3n4)c[nH]c3ncc4Cl)ccn2)cc1 Chemical compound Fc1ccc(C2(CC2)Nc2cc(-c(c3n4)c[nH]c3ncc4Cl)ccn2)cc1 HVWQGCOUJLQMPD-UHFFFAOYSA-N 0.000 description 2
DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
239000007995 HEPES buffer Substances 0.000 description 2
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
208000033761 Myelogenous Chronic BCR-ABL Positive Leukemia Diseases 0.000 description 2
235000019483 Peanut oil Nutrition 0.000 description 2
239000004264 Petrolatum Substances 0.000 description 2
ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
208000033826 Promyelocytic Acute Leukemia Diseases 0.000 description 2
KYQCOXFCLRTKLS-UHFFFAOYSA-N Pyrazine Chemical compound C1=CN=CC=N1 KYQCOXFCLRTKLS-UHFFFAOYSA-N 0.000 description 2
QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 2
239000004480 active ingredient Substances 0.000 description 2
235000010443 alginic acid Nutrition 0.000 description 2
229920000615 alginic acid Polymers 0.000 description 2
229910052783 alkali metal Inorganic materials 0.000 description 2
229910052784 alkaline earth metal Inorganic materials 0.000 description 2
150000001412 amines Chemical class 0.000 description 2
239000007900 aqueous suspension Substances 0.000 description 2
125000005160 aryl oxy alkyl group Chemical group 0.000 description 2
208000006673 asthma Diseases 0.000 description 2
235000019445 benzyl alcohol Nutrition 0.000 description 2
SESFRYSPDFLNCH-UHFFFAOYSA-N benzyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCC1=CC=CC=C1 SESFRYSPDFLNCH-UHFFFAOYSA-N 0.000 description 2
230000037396 body weight Effects 0.000 description 2
150000001642 boronic acid derivatives Chemical class 0.000 description 2
125000005620 boronic acid group Chemical class 0.000 description 2
210000000133 brain stem Anatomy 0.000 description 2
210000000481 breast Anatomy 0.000 description 2
239000000872 buffer Substances 0.000 description 2
239000007853 buffer solution Substances 0.000 description 2
239000002775 capsule Substances 0.000 description 2
125000002837 carbocyclic group Chemical group 0.000 description 2
125000004432 carbon atom Chemical group C* 0.000 description 2
239000004359 castor oil Substances 0.000 description 2
235000019438 castor oil Nutrition 0.000 description 2
230000030833 cell death Effects 0.000 description 2
239000001913 cellulose Substances 0.000 description 2
229920002678 cellulose Polymers 0.000 description 2
235000010980 cellulose Nutrition 0.000 description 2
229910052801 chlorine Inorganic materials 0.000 description 2
229940110456 cocoa butter Drugs 0.000 description 2
235000019868 cocoa butter Nutrition 0.000 description 2
239000003086 colorant Substances 0.000 description 2
229910052802 copper Inorganic materials 0.000 description 2
239000010949 copper Substances 0.000 description 2
DOBRDRYODQBAMW-UHFFFAOYSA-N copper(i) cyanide Chemical compound [Cu+].N#[C-] DOBRDRYODQBAMW-UHFFFAOYSA-N 0.000 description 2
LSXDOTMGLUJQCM-UHFFFAOYSA-M copper(i) iodide Chemical compound I[Cu] LSXDOTMGLUJQCM-UHFFFAOYSA-M 0.000 description 2
235000005687 corn oil Nutrition 0.000 description 2
239000002285 corn oil Substances 0.000 description 2
235000012343 cottonseed oil Nutrition 0.000 description 2
239000002385 cottonseed oil Substances 0.000 description 2
238000005859 coupling reaction Methods 0.000 description 2
230000002939 deleterious effect Effects 0.000 description 2
230000001066 destructive effect Effects 0.000 description 2
238000001514 detection method Methods 0.000 description 2
235000005911 diet Nutrition 0.000 description 2
230000037213 diet Effects 0.000 description 2
239000000839 emulsion Substances 0.000 description 2
238000006911 enzymatic reaction Methods 0.000 description 2
MMXKVMNBHPAILY-UHFFFAOYSA-N ethyl laurate Chemical compound CCCCCCCCCCCC(=O)OCC MMXKVMNBHPAILY-UHFFFAOYSA-N 0.000 description 2
230000029142 excretion Effects 0.000 description 2
150000004665 fatty acids Chemical class 0.000 description 2
238000001914 filtration Methods 0.000 description 2
238000003818 flash chromatography Methods 0.000 description 2
235000013355 food flavoring agent Nutrition 0.000 description 2
210000001035 gastrointestinal tract Anatomy 0.000 description 2
125000005456 glyceride group Chemical group 0.000 description 2
ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 2
230000036541 health Effects 0.000 description 2
238000010438 heat treatment Methods 0.000 description 2
125000004475 heteroaralkyl group Chemical group 0.000 description 2
125000005114 heteroarylalkoxy group Chemical group 0.000 description 2
230000003463 hyperproliferative effect Effects 0.000 description 2
238000000099 in vitro assay Methods 0.000 description 2
238000010348 incorporation Methods 0.000 description 2
239000003701 inert diluent Substances 0.000 description 2
208000015181 infectious disease Diseases 0.000 description 2
238000007917 intracranial administration Methods 0.000 description 2
238000007918 intramuscular administration Methods 0.000 description 2
238000007919 intrasynovial administration Methods 0.000 description 2
238000007913 intrathecal administration Methods 0.000 description 2
238000001990 intravenous administration Methods 0.000 description 2
229910052740 iodine Inorganic materials 0.000 description 2
150000002500 ions Chemical class 0.000 description 2
210000002429 large intestine Anatomy 0.000 description 2
210000000867 larynx Anatomy 0.000 description 2
238000004895 liquid chromatography mass spectrometry Methods 0.000 description 2
239000008297 liquid dosage form Substances 0.000 description 2
208000019423 liver disease Diseases 0.000 description 2
239000000314 lubricant Substances 0.000 description 2
201000005249 lung adenocarcinoma Diseases 0.000 description 2
210000004324 lymphatic system Anatomy 0.000 description 2
239000011777 magnesium Substances 0.000 description 2
229910052749 magnesium Inorganic materials 0.000 description 2
235000019359 magnesium stearate Nutrition 0.000 description 2
230000014759 maintenance of location Effects 0.000 description 2
VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 2
238000004519 manufacturing process Methods 0.000 description 2
239000002480 mineral oil Substances 0.000 description 2
235000010446 mineral oil Nutrition 0.000 description 2
150000007522 mineralic acids Chemical class 0.000 description 2
208000010125 myocardial infarction Diseases 0.000 description 2
229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 2
BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 description 2
LQNUZADURLCDLV-UHFFFAOYSA-N nitrobenzene Chemical compound [O-][N+](=O)C1=CC=CC=C1 LQNUZADURLCDLV-UHFFFAOYSA-N 0.000 description 2
239000000346 nonvolatile oil Substances 0.000 description 2
239000002674 ointment Substances 0.000 description 2
150000007524 organic acids Chemical class 0.000 description 2
235000005985 organic acids Nutrition 0.000 description 2
230000002018 overexpression Effects 0.000 description 2
235000006408 oxalic acid Nutrition 0.000 description 2
230000003647 oxidation Effects 0.000 description 2
238000007254 oxidation reaction Methods 0.000 description 2
210000000496 pancreas Anatomy 0.000 description 2
230000001575 pathological effect Effects 0.000 description 2
239000000312 peanut oil Substances 0.000 description 2
VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 2
229940066842 petrolatum Drugs 0.000 description 2
210000003800 pharynx Anatomy 0.000 description 2
239000010452 phosphate Substances 0.000 description 2
NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
229940080469 phosphocellulose Drugs 0.000 description 2
150000003013 phosphoric acid derivatives Chemical class 0.000 description 2
125000004483 piperidin-3-yl group Chemical group N1CC(CCC1)* 0.000 description 2
229920001451 polypropylene glycol Polymers 0.000 description 2
229910052700 potassium Inorganic materials 0.000 description 2
239000011591 potassium Substances 0.000 description 2
CUQOHAYJWVTKDE-UHFFFAOYSA-N potassium;butan-1-olate Chemical compound [K+].CCCC[O-] CUQOHAYJWVTKDE-UHFFFAOYSA-N 0.000 description 2
210000002307 prostate Anatomy 0.000 description 2
238000000746 purification Methods 0.000 description 2
UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
238000005956 quaternization reaction Methods 0.000 description 2
210000000664 rectum Anatomy 0.000 description 2
239000008159 sesame oil Substances 0.000 description 2
235000011803 sesame oil Nutrition 0.000 description 2
229910052708 sodium Inorganic materials 0.000 description 2
235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 2
229920001027 sodium carboxymethylcellulose Polymers 0.000 description 2
229910000104 sodium hydride Inorganic materials 0.000 description 2
238000007920 subcutaneous administration Methods 0.000 description 2
239000000829 suppository Substances 0.000 description 2
239000000375 suspending agent Substances 0.000 description 2
239000003765 sweetening agent Substances 0.000 description 2
238000003786 synthesis reaction Methods 0.000 description 2
230000001225 therapeutic effect Effects 0.000 description 2
125000004001 thioalkyl group Chemical group 0.000 description 2
239000000080 wetting agent Substances 0.000 description 2
LSPHULWDVZXLIL-UHFFFAOYSA-N (+/-)-Camphoric acid Chemical compound CC1(C)C(C(O)=O)CCC1(C)C(O)=O LSPHULWDVZXLIL-UHFFFAOYSA-N 0.000 description 1
ABJSOROVZZKJGI-OCYUSGCXSA-N (1r,2r,4r)-2-(4-bromophenyl)-n-[(4-chlorophenyl)-(2-fluoropyridin-4-yl)methyl]-4-morpholin-4-ylcyclohexane-1-carboxamide Chemical compound C1=NC(F)=CC(C(NC(=O)[C@H]2[C@@H](C[C@@H](CC2)N2CCOCC2)C=2C=CC(Br)=CC=2)C=2C=CC(Cl)=CC=2)=C1 ABJSOROVZZKJGI-OCYUSGCXSA-N 0.000 description 1
JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
STBLNCCBQMHSRC-BATDWUPUSA-N (2s)-n-[(3s,4s)-5-acetyl-7-cyano-4-methyl-1-[(2-methylnaphthalen-1-yl)methyl]-2-oxo-3,4-dihydro-1,5-benzodiazepin-3-yl]-2-(methylamino)propanamide Chemical compound O=C1[C@@H](NC(=O)[C@H](C)NC)[C@H](C)N(C(C)=O)C2=CC(C#N)=CC=C2N1CC1=C(C)C=CC2=CC=CC=C12 STBLNCCBQMHSRC-BATDWUPUSA-N 0.000 description 1
AFSSVCNPDKKSRR-UHFFFAOYSA-N (3-bromophenyl)boronic acid Chemical compound OB(O)C1=CC=CC(Br)=C1 AFSSVCNPDKKSRR-UHFFFAOYSA-N 0.000 description 1
IWZSHWBGHQBIML-ZGGLMWTQSA-N (3S,8S,10R,13S,14S,17S)-17-isoquinolin-7-yl-N,N,10,13-tetramethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-amine Chemical compound CN(C)[C@H]1CC[C@]2(C)C3CC[C@@]4(C)[C@@H](CC[C@@H]4c4ccc5ccncc5c4)[C@@H]3CC=C2C1 IWZSHWBGHQBIML-ZGGLMWTQSA-N 0.000 description 1
WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
125000004502 1,2,3-oxadiazolyl group Chemical group 0.000 description 1
125000004504 1,2,4-oxadiazolyl group Chemical group 0.000 description 1
125000004506 1,2,5-oxadiazolyl group Chemical group 0.000 description 1
125000004517 1,2,5-thiadiazolyl group Chemical group 0.000 description 1
125000004520 1,3,4-thiadiazolyl group Chemical group 0.000 description 1
125000003363 1,3,5-triazinyl group Chemical group N1=C(N=CN=C1)* 0.000 description 1
229940058015 1,3-butylene glycol Drugs 0.000 description 1
AICIYIDUYNFPRY-UHFFFAOYSA-N 1,3-dihydro-2H-imidazol-2-one Chemical compound O=C1NC=CN1 AICIYIDUYNFPRY-UHFFFAOYSA-N 0.000 description 1
RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
125000001462 1-pyrrolyl group Chemical group [*]N1C([H])=C([H])C([H])=C1[H] 0.000 description 1
YJUFGFXVASPYFQ-UHFFFAOYSA-N 2,3-dihydro-1-benzothiophene Chemical compound C1=CC=C2SCCC2=C1 YJUFGFXVASPYFQ-UHFFFAOYSA-N 0.000 description 1
CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 description 1
WIGDGIGALMYEBW-LLINQDLYSA-N 2-[[(2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-amino-4-methylpentanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]propanoyl]amino]-3-hydroxypropanoyl]amino]-4-methylpentanoyl]amino]acetic acid Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O WIGDGIGALMYEBW-LLINQDLYSA-N 0.000 description 1
YSUIQYOGTINQIN-UZFYAQMZSA-N 2-amino-9-[(1S,6R,8R,9S,10R,15R,17R,18R)-8-(6-aminopurin-9-yl)-9,18-difluoro-3,12-dihydroxy-3,12-bis(sulfanylidene)-2,4,7,11,13,16-hexaoxa-3lambda5,12lambda5-diphosphatricyclo[13.2.1.06,10]octadecan-17-yl]-1H-purin-6-one Chemical compound NC1=NC2=C(N=CN2[C@@H]2O[C@@H]3COP(S)(=O)O[C@@H]4[C@@H](COP(S)(=O)O[C@@H]2[C@@H]3F)O[C@H]([C@H]4F)N2C=NC3=C2N=CN=C3N)C(=O)N1 YSUIQYOGTINQIN-UZFYAQMZSA-N 0.000 description 1
TVTJUIAKQFIXCE-HUKYDQBMSA-N 2-amino-9-[(2R,3S,4S,5R)-4-fluoro-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-7-prop-2-ynyl-1H-purine-6,8-dione Chemical compound NC=1NC(C=2N(C(N(C=2N=1)[C@@H]1O[C@@H]([C@H]([C@H]1O)F)CO)=O)CC#C)=O TVTJUIAKQFIXCE-HUKYDQBMSA-N 0.000 description 1
125000002941 2-furyl group Chemical group O1C([*])=C([H])C([H])=C1[H] 0.000 description 1
229940080296 2-naphthalenesulfonate Drugs 0.000 description 1
LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 1
125000004105 2-pyridyl group Chemical group N1=C([*])C([H])=C([H])C([H])=C1[H] 0.000 description 1
125000004485 2-pyrrolidinyl group Chemical group [H]N1C([H])([H])C([H])([H])C([H])([H])C1([H])* 0.000 description 1
125000000389 2-pyrrolyl group Chemical group [H]N1C([*])=C([H])C([H])=C1[H] 0.000 description 1
125000000175 2-thienyl group Chemical group S1C([*])=C([H])C([H])=C1[H] 0.000 description 1
LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
FSUYMKXZLQOFQY-UHFFFAOYSA-N 3,4-dihydro-1,2-benzodithiine Chemical compound C1=CC=C2SSCCC2=C1 FSUYMKXZLQOFQY-UHFFFAOYSA-N 0.000 description 1
BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
ZRPLANDPDWYOMZ-UHFFFAOYSA-N 3-cyclopentylpropionic acid Chemical compound OC(=O)CCC1CCCC1 ZRPLANDPDWYOMZ-UHFFFAOYSA-N 0.000 description 1
125000003682 3-furyl group Chemical group O1C([H])=C([*])C([H])=C1[H] 0.000 description 1
XMIIGOLPHOKFCH-UHFFFAOYSA-M 3-phenylpropionate Chemical compound [O-]C(=O)CCC1=CC=CC=C1 XMIIGOLPHOKFCH-UHFFFAOYSA-M 0.000 description 1
125000003349 3-pyridyl group Chemical group N1=C([H])C([*])=C([H])C([H])=C1[H] 0.000 description 1
125000004575 3-pyrrolidinyl group Chemical group [H]N1C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
125000001397 3-pyrrolyl group Chemical group [H]N1C([H])=C([*])C([H])=C1[H] 0.000 description 1
125000001541 3-thienyl group Chemical group S1C([H])=C([*])C([H])=C1[H] 0.000 description 1
125000000339 4-pyridyl group Chemical group N1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 description 1
KDDQRKBRJSGMQE-UHFFFAOYSA-N 4-thiazolyl Chemical group [C]1=CSC=N1 KDDQRKBRJSGMQE-UHFFFAOYSA-N 0.000 description 1
125000006163 5-membered heteroaryl group Chemical group 0.000 description 1
CWDWFSXUQODZGW-UHFFFAOYSA-N 5-thiazolyl Chemical group [C]1=CN=CS1 CWDWFSXUQODZGW-UHFFFAOYSA-N 0.000 description 1
FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
108091006112 ATPases Proteins 0.000 description 1
QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
208000031261 Acute myeloid leukaemia Diseases 0.000 description 1
208000036832 Adenocarcinoma of ovary Diseases 0.000 description 1
208000003200 Adenoma Diseases 0.000 description 1
206010001233 Adenoma benign Diseases 0.000 description 1
102000057290 Adenosine Triphosphatases Human genes 0.000 description 1
229920001817 Agar Polymers 0.000 description 1
GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
241000416162 Astragalus gummifer Species 0.000 description 1
102000004000 Aurora Kinase A Human genes 0.000 description 1
108090000461 Aurora Kinase A Proteins 0.000 description 1
229940123877 Aurora kinase inhibitor Drugs 0.000 description 1
108010017384 Blood Proteins Proteins 0.000 description 1
102000004506 Blood Proteins Human genes 0.000 description 1
208000019838 Blood disease Diseases 0.000 description 1
VYKNRZHBAUEDDS-UHFFFAOYSA-N Brc1cccc(-c(c2n3)c[nH]c2ncc3Br)c1 Chemical compound Brc1cccc(-c(c2n3)c[nH]c2ncc3Br)c1 VYKNRZHBAUEDDS-UHFFFAOYSA-N 0.000 description 1
CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
238000006443 Buchwald-Hartwig cross coupling reaction Methods 0.000 description 1
FERIUCNNQQJTOY-UHFFFAOYSA-M Butyrate Chemical compound CCCC([O-])=O FERIUCNNQQJTOY-UHFFFAOYSA-M 0.000 description 1
FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Natural products CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 1
ZEFVNOWXXFRWKJ-UHFFFAOYSA-N C(C1)C1(C1=CC=CCC1)Nc1cc(-c2c[nH]c(N=C3)c2NC3c2ccncc2)ccc1 Chemical compound C(C1)C1(C1=CC=CCC1)Nc1cc(-c2c[nH]c(N=C3)c2NC3c2ccncc2)ccc1 ZEFVNOWXXFRWKJ-UHFFFAOYSA-N 0.000 description 1
NCTRUBMXGSEREG-UHFFFAOYSA-N C(C1)C1(c1ccccc1)Nc1cc(-c2c[nH]c3ncc(-c4ccccc4)nc23)ccc1 Chemical compound C(C1)C1(c1ccccc1)Nc1cc(-c2c[nH]c3ncc(-c4ccccc4)nc23)ccc1 NCTRUBMXGSEREG-UHFFFAOYSA-N 0.000 description 1
IEMRHOQRLYWBGW-UHFFFAOYSA-N C(C1)C1(c1ccccc1)Nc1cc(-c2c[nH]c3ncc(-c4cccnc4)nc23)ccc1 Chemical compound C(C1)C1(c1ccccc1)Nc1cc(-c2c[nH]c3ncc(-c4cccnc4)nc23)ccc1 IEMRHOQRLYWBGW-UHFFFAOYSA-N 0.000 description 1
PTCFIGUNHJNAMU-UHFFFAOYSA-N C(C1)C1(c1ccccc1)Nc1cc(-c2c[nH]c3ncc(-c4ccncc4)nc23)ccc1 Chemical compound C(C1)C1(c1ccccc1)Nc1cc(-c2c[nH]c3ncc(-c4ccncc4)nc23)ccc1 PTCFIGUNHJNAMU-UHFFFAOYSA-N 0.000 description 1
BHJQCTWRRGVNNF-UHFFFAOYSA-N C=[Br]c1cccc(-c(c2n3)c[nH]c2ncc3Br)c1 Chemical compound C=[Br]c1cccc(-c(c2n3)c[nH]c2ncc3Br)c1 BHJQCTWRRGVNNF-UHFFFAOYSA-N 0.000 description 1
OMHWCLGIFVYQPR-UHFFFAOYSA-N CC(C)C(Nc1nc(-c2c[nH]c(N=C3)c2NC3Cl)ccc1)=O Chemical compound CC(C)C(Nc1nc(-c2c[nH]c(N=C3)c2NC3Cl)ccc1)=O OMHWCLGIFVYQPR-UHFFFAOYSA-N 0.000 description 1
OYAYBDQMOVCHCQ-ULJHMMPZSA-N CC(CCC=C1)=C1Nc1nc(-c2c[nH]c(N)c2/N=C(/Cl)\I)ccc1 Chemical compound CC(CCC=C1)=C1Nc1nc(-c2c[nH]c(N)c2/N=C(/Cl)\I)ccc1 OYAYBDQMOVCHCQ-ULJHMMPZSA-N 0.000 description 1
GVLNOJFWDKWQJJ-UHFFFAOYSA-N CC(CN1)(C(C)(C2)C=NC(F)=C2NC2(CC2)C2=CCCC=C2)c2c1ncc(Cl)n2 Chemical compound CC(CN1)(C(C)(C2)C=NC(F)=C2NC2(CC2)C2=CCCC=C2)c2c1ncc(Cl)n2 GVLNOJFWDKWQJJ-UHFFFAOYSA-N 0.000 description 1
ZKDUHZVHALGGEJ-UHFFFAOYSA-N CC(CN1)(C2=C1NCC(Cl)=N2)c(cc1NC2(CC2)c2ccccc2)ncc1F Chemical compound CC(CN1)(C2=C1NCC(Cl)=N2)c(cc1NC2(CC2)c2ccccc2)ncc1F ZKDUHZVHALGGEJ-UHFFFAOYSA-N 0.000 description 1
QIDLVFUCUOSSSI-UHFFFAOYSA-N CC(NC1=Nc(c(-c2cccc(NC3(CC3)c3ccccc3)c2)c[nH]2)c2NC1)=O Chemical compound CC(NC1=Nc(c(-c2cccc(NC3(CC3)c3ccccc3)c2)c[nH]2)c2NC1)=O QIDLVFUCUOSSSI-UHFFFAOYSA-N 0.000 description 1
FZJQPKXRTRLOKN-UHFFFAOYSA-N CC(Nc(nc12)cnc1[nH]cc2-c1cccc(NC2(CC2)c2ccccc2)c1)=O Chemical compound CC(Nc(nc12)cnc1[nH]cc2-c1cccc(NC2(CC2)c2ccccc2)c1)=O FZJQPKXRTRLOKN-UHFFFAOYSA-N 0.000 description 1
ROECCDDCZWGMIL-UHFFFAOYSA-N CC1(c2nc(C)cnc2NC1)c1cccc(NC2(CC2)c2ccccc2)n1 Chemical compound CC1(c2nc(C)cnc2NC1)c1cccc(NC2(CC2)c2ccccc2)n1 ROECCDDCZWGMIL-UHFFFAOYSA-N 0.000 description 1
DZSDDDVAXLHFFO-UHFFFAOYSA-N CC1=CN=C2NC=CC2N1 Chemical compound CC1=CN=C2NC=CC2N1 DZSDDDVAXLHFFO-UHFFFAOYSA-N 0.000 description 1
BRZVSFNBKNOXBX-UHFFFAOYSA-N CC1Nc(c(-c2cccc(NC3(CC3)c3ccccc3)c2)c[nH]2)c2N=C1 Chemical compound CC1Nc(c(-c2cccc(NC3(CC3)c3ccccc3)c2)c[nH]2)c2N=C1 BRZVSFNBKNOXBX-UHFFFAOYSA-N 0.000 description 1
RQNTVWYBJVRKNN-UHFFFAOYSA-N CCC(C)C(C)CCNc(nc12)cnc1[nH]cc2-c1cccc(Br)c1 Chemical compound CCC(C)C(C)CCNc(nc12)cnc1[nH]cc2-c1cccc(Br)c1 RQNTVWYBJVRKNN-UHFFFAOYSA-N 0.000 description 1
YLUDSYGJHAQGOD-UHFFFAOYSA-N CCC1CNCCC1 Chemical compound CCC1CNCCC1 YLUDSYGJHAQGOD-UHFFFAOYSA-N 0.000 description 1
PDDDRLDENIVHKH-MQEHRNTISA-N CC[IH]/C=N\C(\N)=C(\C(c1ccnc(NC2(CC2)c2ccccc2)c1)=N)/N Chemical compound CC[IH]/C=N\C(\N)=C(\C(c1ccnc(NC2(CC2)c2ccccc2)c1)=N)/N PDDDRLDENIVHKH-MQEHRNTISA-N 0.000 description 1
ZMAJPMPBYIZNQJ-UHFFFAOYSA-N CCc(nc12)ccc1[nH]cc2-c1cccc(NC(C(C)C)=O)n1 Chemical compound CCc(nc12)ccc1[nH]cc2-c1cccc(NC(C(C)C)=O)n1 ZMAJPMPBYIZNQJ-UHFFFAOYSA-N 0.000 description 1
ZWCVXRMLUTWCCH-UHFFFAOYSA-N CCc(nc12)cnc1NCC2c1cccc(SCc2ccccc2)c1 Chemical compound CCc(nc12)cnc1NCC2c1cccc(SCc2ccccc2)c1 ZWCVXRMLUTWCCH-UHFFFAOYSA-N 0.000 description 1
UGDOUAJXQFLJNV-UHFFFAOYSA-N CCc(nc12)cnc1[nH]cc2-c(cc1NCC2CNCCC2)ccc1F Chemical compound CCc(nc12)cnc1[nH]cc2-c(cc1NCC2CNCCC2)ccc1F UGDOUAJXQFLJNV-UHFFFAOYSA-N 0.000 description 1
BCIAKNVWLSGJRG-UHFFFAOYSA-N CCc(nc12)cnc1[nH]cc2-c1ccnc(NC2(CC2)c2ccccc2)c1 Chemical compound CCc(nc12)cnc1[nH]cc2-c1ccnc(NC2(CC2)c2ccccc2)c1 BCIAKNVWLSGJRG-UHFFFAOYSA-N 0.000 description 1
QLUFKODDOWSUCF-UHFFFAOYSA-N CCc(nc12)cnc1[nH]cc2-c1cncc(NC2(CC2)c2ccccc2)c1 Chemical compound CCc(nc12)cnc1[nH]cc2-c1cncc(NC2(CC2)c2ccccc2)c1 QLUFKODDOWSUCF-UHFFFAOYSA-N 0.000 description 1
IELNOKAQTXNAJZ-UHFFFAOYSA-N CCc(nc12)cnc1[nH]cc2C(C=CC1)=CC1NC1(CC1)C1=CCC(C)C=C1 Chemical compound CCc(nc12)cnc1[nH]cc2C(C=CC1)=CC1NC1(CC1)C1=CCC(C)C=C1 IELNOKAQTXNAJZ-UHFFFAOYSA-N 0.000 description 1
HGPRNCYXXFGZOO-UHFFFAOYSA-N CCc(nc12)cnc1[nH]cc2C(N=CC1F)=NC1NC1(CC1)c1ccccc1 Chemical compound CCc(nc12)cnc1[nH]cc2C(N=CC1F)=NC1NC1(CC1)c1ccccc1 HGPRNCYXXFGZOO-UHFFFAOYSA-N 0.000 description 1
ANIANTRHXVMEJS-UHFFFAOYSA-N CCc1nc(c(-c(cc2NCC3CCNCC3)ccc2F)c[nH]2)c2nc1 Chemical compound CCc1nc(c(-c(cc2NCC3CCNCC3)ccc2F)c[nH]2)c2nc1 ANIANTRHXVMEJS-UHFFFAOYSA-N 0.000 description 1
YPAMAJNWUZBRFI-UHFFFAOYSA-N CN(C)CCNc(nc12)cnc1[nH]cc2-c1cccc(Br)c1 Chemical compound CN(C)CCNc(nc12)cnc1[nH]cc2-c1cccc(Br)c1 YPAMAJNWUZBRFI-UHFFFAOYSA-N 0.000 description 1
AMPAFQWBRREERB-UHFFFAOYSA-N CN(C)CCNc(nc12)cnc1[nH]nc2-c1cccc([Br]=C)c1 Chemical compound CN(C)CCNc(nc12)cnc1[nH]nc2-c1cccc([Br]=C)c1 AMPAFQWBRREERB-UHFFFAOYSA-N 0.000 description 1
RULXLSMEIAUDPE-UHFFFAOYSA-N CN(C)CCOc1cc(C2(CC2)NC2N=C(c(c3n4)c[nH]c3ncc4Cl)N=CC2F)ccc1 Chemical compound CN(C)CCOc1cc(C2(CC2)NC2N=C(c(c3n4)c[nH]c3ncc4Cl)N=CC2F)ccc1 RULXLSMEIAUDPE-UHFFFAOYSA-N 0.000 description 1
JCXIZKQMOPRCAH-DBFSUHOCSA-N CN(C)CCOc1cc(C2(CC2)Nc2nc(-c3c[nH]c(/N=C\[IH]Cl)c3N)ncc2F)ccc1 Chemical compound CN(C)CCOc1cc(C2(CC2)Nc2nc(-c3c[nH]c(/N=C\[IH]Cl)c3N)ncc2F)ccc1 JCXIZKQMOPRCAH-DBFSUHOCSA-N 0.000 description 1
GJXGQMGEJMSWSO-UHFFFAOYSA-N CN(C)Cc1[n+](Cc2c[nH]c(nc3)c2nc3Cl)[n-]c(NC2(CC2)c(cc2)ccc2F)c1 Chemical compound CN(C)Cc1[n+](Cc2c[nH]c(nc3)c2nc3Cl)[n-]c(NC2(CC2)c(cc2)ccc2F)c1 GJXGQMGEJMSWSO-UHFFFAOYSA-N 0.000 description 1
OWPHMBASLFHTMZ-UHFFFAOYSA-N CN(C)Cc1cc(NC2(CC2)c(cc2)ccc2F)nc(-c(c2n3)c[nH]c2ncc3Cl)n1 Chemical compound CN(C)Cc1cc(NC2(CC2)c(cc2)ccc2F)nc(-c(c2n3)c[nH]c2ncc3Cl)n1 OWPHMBASLFHTMZ-UHFFFAOYSA-N 0.000 description 1
SAXOOBVTLPHABU-UHFFFAOYSA-N CNc(nc12)cnc1[nH]cc2-c1cccc(NC2(CC2)C2=CC=CCC2)c1 Chemical compound CNc(nc12)cnc1[nH]cc2-c1cccc(NC2(CC2)C2=CC=CCC2)c1 SAXOOBVTLPHABU-UHFFFAOYSA-N 0.000 description 1
VGDAUOCCEAFJFB-FMQZQXMHSA-N CNc1nc(-c2c[nH]c(/N=C\[IH]Cl)c2N)ccc1 Chemical compound CNc1nc(-c2c[nH]c(/N=C\[IH]Cl)c2N)ccc1 VGDAUOCCEAFJFB-FMQZQXMHSA-N 0.000 description 1
UFAKESMXSWORPF-UHFFFAOYSA-N CNc1nc(c(-c2cccc(NC3(CC3)c3ccccc3)c2)c[nH]2)c2[n]c1 Chemical compound CNc1nc(c(-c2cccc(NC3(CC3)c3ccccc3)c2)c[nH]2)c2[n]c1 UFAKESMXSWORPF-UHFFFAOYSA-N 0.000 description 1
BFTAFBMPEZFHLW-UHFFFAOYSA-N C[BrH]c(nc12)cnc1[nH]cc2-c1cccc(NC2(CC2)c2ccccc2)c1 Chemical compound C[BrH]c(nc12)cnc1[nH]cc2-c1cccc(NC2(CC2)c2ccccc2)c1 BFTAFBMPEZFHLW-UHFFFAOYSA-N 0.000 description 1
MPDCKQJRQCDRFE-ZETCQYMHSA-N C[C@@H](C(NC1CC1)=O)Nc1nc(-c2n[nH]c(nc3)c2nc3Cl)ncc1 Chemical compound C[C@@H](C(NC1CC1)=O)Nc1nc(-c2n[nH]c(nc3)c2nc3Cl)ncc1 MPDCKQJRQCDRFE-ZETCQYMHSA-N 0.000 description 1
NLAQIIQGJBTSGV-YLXOKPIJSA-N C[C@@H](C(NC1CC1)=O)Nc1nc(C2=NNC3N=CC(Cl)=NC23)ncc1 Chemical compound C[C@@H](C(NC1CC1)=O)Nc1nc(C2=NNC3N=CC(Cl)=NC23)ncc1 NLAQIIQGJBTSGV-YLXOKPIJSA-N 0.000 description 1
OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
OKTJSMMVPCPJKN-OUBTZVSYSA-N Carbon-13 Chemical compound [13C] OKTJSMMVPCPJKN-OUBTZVSYSA-N 0.000 description 1
229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
201000009030 Carcinoma Diseases 0.000 description 1
208000010667 Carcinoma of liver and intrahepatic biliary tract Diseases 0.000 description 1
208000020446 Cardiac disease Diseases 0.000 description 1
206010007559 Cardiac failure congestive Diseases 0.000 description 1
206010007572 Cardiac hypertrophy Diseases 0.000 description 1
208000006029 Cardiomegaly Diseases 0.000 description 1
208000024172 Cardiovascular disease Diseases 0.000 description 1
ZIRUIXGSFKHNJL-UHFFFAOYSA-N Cc(cccc1)c1Nc1nc(-c2c[nH]c3ncc(C)nc23)ccc1 Chemical compound Cc(cccc1)c1Nc1nc(-c2c[nH]c3ncc(C)nc23)ccc1 ZIRUIXGSFKHNJL-UHFFFAOYSA-N 0.000 description 1
DGWDPGBRCFUBGO-UHFFFAOYSA-N Cc(nc12)cnc1[nH]cc2-c(cc1)cc(NCC2NCCCC2)c1F Chemical compound Cc(nc12)cnc1[nH]cc2-c(cc1)cc(NCC2NCCCC2)c1F DGWDPGBRCFUBGO-UHFFFAOYSA-N 0.000 description 1
HGAGLJKOUDSDFU-UHFFFAOYSA-N Cc(nc12)cnc1[nH]cc2-c1nc(Br)ccc1 Chemical compound Cc(nc12)cnc1[nH]cc2-c1nc(Br)ccc1 HGAGLJKOUDSDFU-UHFFFAOYSA-N 0.000 description 1
KBAWWMPVWAHDGN-UHFFFAOYSA-N Cc(nc12)cnc1[nH]cc2-c1ncc(C(O)=O)c(NC2(CC2)c(cc2)ccc2F)n1 Chemical compound Cc(nc12)cnc1[nH]cc2-c1ncc(C(O)=O)c(NC2(CC2)c(cc2)ccc2F)n1 KBAWWMPVWAHDGN-UHFFFAOYSA-N 0.000 description 1
NXMOHBMAFZAUDD-UHFFFAOYSA-N Cc(nc1C(c2nccc(NC3(CC3)C(N(C)C)=O)n2)=N)cnc1N Chemical compound Cc(nc1C(c2nccc(NC3(CC3)C(N(C)C)=O)n2)=N)cnc1N NXMOHBMAFZAUDD-UHFFFAOYSA-N 0.000 description 1
VZTYMWLDBOUJBB-UHFFFAOYSA-N Cc1c(NC2(CC2)c(cc2)ccc2F)nc(-c(c2n3)c[nH]c2ncc3Cl)nc1 Chemical compound Cc1c(NC2(CC2)c(cc2)ccc2F)nc(-c(c2n3)c[nH]c2ncc3Cl)nc1 VZTYMWLDBOUJBB-UHFFFAOYSA-N 0.000 description 1
DNMBHXLXMZZJHN-UHFFFAOYSA-N Cc1nc(c(-c2cccc(N3CCNCC3)n2)c[nH]2)c2[n]c1 Chemical compound Cc1nc(c(-c2cccc(N3CCNCC3)n2)c[nH]2)c2[n]c1 DNMBHXLXMZZJHN-UHFFFAOYSA-N 0.000 description 1
VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
VGCXGMAHQTYDJK-UHFFFAOYSA-N Chloroacetyl chloride Chemical class ClCC(Cl)=O VGCXGMAHQTYDJK-UHFFFAOYSA-N 0.000 description 1
KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
PVTPDLQWCUMIJI-UHFFFAOYSA-N ClC1=Nc(c(-c2cccc(Br)n2)c[nH]2)c2NC1 Chemical compound ClC1=Nc(c(-c2cccc(Br)n2)c[nH]2)c2NC1 PVTPDLQWCUMIJI-UHFFFAOYSA-N 0.000 description 1
SCPZCYMHBKWULU-UHFFFAOYSA-N ClC1Nc(c(-c2cccc(Br)c2)n[nH]2)c2N=C1 Chemical compound ClC1Nc(c(-c2cccc(Br)c2)n[nH]2)c2N=C1 SCPZCYMHBKWULU-UHFFFAOYSA-N 0.000 description 1
PUMIEZDYYKHALE-UHFFFAOYSA-N ClC1Nc(c(-c2cccc(Nc3cccc(Cl)c3)n2)c[nH]2)c2N=C1 Chemical compound ClC1Nc(c(-c2cccc(Nc3cccc(Cl)c3)n2)c[nH]2)c2N=C1 PUMIEZDYYKHALE-UHFFFAOYSA-N 0.000 description 1
ZXLFNUKBQBDQHA-UHFFFAOYSA-N ClC1Nc(c(-c2nccc(NC3(CC3)c3ccccc3)c2)c[nH]2)c2N=C1 Chemical compound ClC1Nc(c(-c2nccc(NC3(CC3)c3ccccc3)c2)c[nH]2)c2N=C1 ZXLFNUKBQBDQHA-UHFFFAOYSA-N 0.000 description 1
RHYGQQIPIKPJMN-UHFFFAOYSA-N Clc(cccc1)c1Sc1nc(-c(c2n3)c[nH]c2ncc3Cl)ccc1 Chemical compound Clc(cccc1)c1Sc1nc(-c(c2n3)c[nH]c2ncc3Cl)ccc1 RHYGQQIPIKPJMN-UHFFFAOYSA-N 0.000 description 1
KQAAQJRMKCNCOU-UHFFFAOYSA-N Clc(nc12)cnc1N=CC2c1ccnc(NC2(CC2)c2ccccc2)c1 Chemical compound Clc(nc12)cnc1N=CC2c1ccnc(NC2(CC2)c2ccccc2)c1 KQAAQJRMKCNCOU-UHFFFAOYSA-N 0.000 description 1
AULXTCPUDWZCPY-UHFFFAOYSA-N Clc(nc12)cnc1[nH]cc2-c1cccc(NCCc2ccccc2)n1 Chemical compound Clc(nc12)cnc1[nH]cc2-c1cccc(NCCc2ccccc2)n1 AULXTCPUDWZCPY-UHFFFAOYSA-N 0.000 description 1
SIWXGSUETHWSKW-UHFFFAOYSA-N Clc(nc12)cnc1[nH]cc2-c1cccc(NCc2ccccc2)n1 Chemical compound Clc(nc12)cnc1[nH]cc2-c1cccc(NCc2ccccc2)n1 SIWXGSUETHWSKW-UHFFFAOYSA-N 0.000 description 1
OXTOOCHISORFNQ-UHFFFAOYSA-N Clc(nc12)cnc1[nH]cc2-c1cccc(Nc2ccccc2)n1 Chemical compound Clc(nc12)cnc1[nH]cc2-c1cccc(Nc2ccccc2)n1 OXTOOCHISORFNQ-UHFFFAOYSA-N 0.000 description 1
XOSCACMUKUERBQ-UHFFFAOYSA-N Clc(nc12)cnc1[nH]cc2-c1cccc(SCc2ccccc2)c1 Chemical compound Clc(nc12)cnc1[nH]cc2-c1cccc(SCc2ccccc2)c1 XOSCACMUKUERBQ-UHFFFAOYSA-N 0.000 description 1
DZEWIWQHXYIHRE-UHFFFAOYSA-N Clc(nc12)cnc1[nH]nc2-c1cccc(Br)c1 Chemical compound Clc(nc12)cnc1[nH]nc2-c1cccc(Br)c1 DZEWIWQHXYIHRE-UHFFFAOYSA-N 0.000 description 1
WVTABOGIQXAPJW-UHFFFAOYSA-N Clc1ccc(CNc2nc(-c(c3n4)c[nH]c3ncc4Cl)ccc2)cc1 Chemical compound Clc1ccc(CNc2nc(-c(c3n4)c[nH]c3ncc4Cl)ccc2)cc1 WVTABOGIQXAPJW-UHFFFAOYSA-N 0.000 description 1
QEGZXJDVASZFON-UHFFFAOYSA-N Clc1nc(c(-c2cccc(NC3(CC3)c3ccccc3)c2)c[nH]2)c2nc1 Chemical compound Clc1nc(c(-c2cccc(NC3(CC3)c3ccccc3)c2)c[nH]2)c2nc1 QEGZXJDVASZFON-UHFFFAOYSA-N 0.000 description 1
KVZRNCCTBLLFCB-UHFFFAOYSA-N Clc1nc(c(-c2cncc(NC3(CC3)c3ccccc3)c2)c[nH]2)c2nc1 Chemical compound Clc1nc(c(-c2cncc(NC3(CC3)c3ccccc3)c2)c[nH]2)c2nc1 KVZRNCCTBLLFCB-UHFFFAOYSA-N 0.000 description 1
206010052360 Colorectal adenocarcinoma Diseases 0.000 description 1
RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
201000003883 Cystic fibrosis Diseases 0.000 description 1
YZCKVEUIGOORGS-OUBTZVSYSA-N Deuterium Chemical compound [2H] YZCKVEUIGOORGS-OUBTZVSYSA-N 0.000 description 1
LVGKNOAMLMIIKO-UHFFFAOYSA-N Elaidinsaeure-aethylester Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC LVGKNOAMLMIIKO-UHFFFAOYSA-N 0.000 description 1
206010014733 Endometrial cancer Diseases 0.000 description 1
206010014759 Endometrial neoplasm Diseases 0.000 description 1
241000792859 Enema Species 0.000 description 1
239000001856 Ethyl cellulose Substances 0.000 description 1
ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
LQDVIZKUZMMJMA-UHFFFAOYSA-N Fc(c(NC1(CC1)c1ccccc1)c1)ccc1-c1c[nH]c(N=C2)c1NC2Cl Chemical compound Fc(c(NC1(CC1)c1ccccc1)c1)ccc1-c1c[nH]c(N=C2)c1NC2Cl LQDVIZKUZMMJMA-UHFFFAOYSA-N 0.000 description 1
CQBJYDVARSMLEQ-UHFFFAOYSA-N Fc(c(NC1(CC1)c1ccccc1)c1)cnc1-c(c1n2)c[nH]c1ncc2Cl Chemical compound Fc(c(NC1(CC1)c1ccccc1)c1)cnc1-c(c1n2)c[nH]c1ncc2Cl CQBJYDVARSMLEQ-UHFFFAOYSA-N 0.000 description 1
JNDASLSDHWSUFO-UHFFFAOYSA-N Fc(c(NCC1=NCCC=C1)c1)ccc1-c1c[nH]c(NC2)c1N=C2Cl Chemical compound Fc(c(NCC1=NCCC=C1)c1)ccc1-c1c[nH]c(NC2)c1N=C2Cl JNDASLSDHWSUFO-UHFFFAOYSA-N 0.000 description 1
PBTFCIXPBHJZKD-UHFFFAOYSA-N Fc(c(NCC1NCCCC1)c1)ccc1-c1c[nH]c(N=C2)c1NC2Cl Chemical compound Fc(c(NCC1NCCCC1)c1)ccc1-c1c[nH]c(N=C2)c1NC2Cl PBTFCIXPBHJZKD-UHFFFAOYSA-N 0.000 description 1
IDEUAXMJHJRYPJ-UHFFFAOYSA-N Fc(c(NCc1ccncc1)c1)ccc1-c(c1n2)c[nH]c1ncc2Cl Chemical compound Fc(c(NCc1ccncc1)c1)ccc1-c(c1n2)c[nH]c1ncc2Cl IDEUAXMJHJRYPJ-UHFFFAOYSA-N 0.000 description 1
BDAGIHXWWSANSR-UHFFFAOYSA-M Formate Chemical compound [O-]C=O BDAGIHXWWSANSR-UHFFFAOYSA-M 0.000 description 1
238000005727 Friedel-Crafts reaction Methods 0.000 description 1
VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 1
108010010803 Gelatin Proteins 0.000 description 1
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
239000004471 Glycine Substances 0.000 description 1
AEMRFAOFKBGASW-UHFFFAOYSA-M Glycolate Chemical compound OCC([O-])=O AEMRFAOFKBGASW-UHFFFAOYSA-M 0.000 description 1
206010019280 Heart failures Diseases 0.000 description 1
206010073069 Hepatic cancer Diseases 0.000 description 1
206010019842 Hepatomegaly Diseases 0.000 description 1
101001059454 Homo sapiens Serine/threonine-protein kinase MARK2 Proteins 0.000 description 1
102000008100 Human Serum Albumin Human genes 0.000 description 1
108091006905 Human Serum Albumin Proteins 0.000 description 1
CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 1
108010020056 Hydrogenase Proteins 0.000 description 1
206010020751 Hypersensitivity Diseases 0.000 description 1
206010020772 Hypertension Diseases 0.000 description 1
206010021143 Hypoxia Diseases 0.000 description 1
208000029462 Immunodeficiency disease Diseases 0.000 description 1
241001481824 Indri Species 0.000 description 1
CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
239000005517 L01XE01 - Imatinib Substances 0.000 description 1
239000005551 L01XE03 - Erlotinib Substances 0.000 description 1
JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
206010023825 Laryngeal cancer Diseases 0.000 description 1
WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
OFOBLEOULBTSOW-UHFFFAOYSA-L Malonate Chemical compound [O-]C(=O)CC([O-])=O OFOBLEOULBTSOW-UHFFFAOYSA-L 0.000 description 1
241000124008 Mammalia Species 0.000 description 1
241001465754 Metazoa Species 0.000 description 1
AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 1
GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 description 1
OPFJDXRVMFKJJO-ZHHKINOHSA-N N-{[3-(2-benzamido-4-methyl-1,3-thiazol-5-yl)-pyrazol-5-yl]carbonyl}-G-dR-G-dD-dD-dD-NH2 Chemical compound S1C(C=2NN=C(C=2)C(=O)NCC(=O)N[C@H](CCCN=C(N)N)C(=O)NCC(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC(O)=O)C(N)=O)=C(C)N=C1NC(=O)C1=CC=CC=C1 OPFJDXRVMFKJJO-ZHHKINOHSA-N 0.000 description 1
XDBCLWQHIVEPRC-UHFFFAOYSA-N NC(c1ccc(-c(c2n3)c[nH]c2ncc3Cl)nc1NC1(CC1)c(cc1)ccc1F)=O Chemical compound NC(c1ccc(-c(c2n3)c[nH]c2ncc3Cl)nc1NC1(CC1)c(cc1)ccc1F)=O XDBCLWQHIVEPRC-UHFFFAOYSA-N 0.000 description 1
DJLOGXFUINLZAP-UHFFFAOYSA-N NC(c1ccc(-c2c[nH]c(N=C3)c2NC3Cl)nc1NC1(CC1)c(cc1)ccc1F)=O Chemical compound NC(c1ccc(-c2c[nH]c(N=C3)c2NC3Cl)nc1NC1(CC1)c(cc1)ccc1F)=O DJLOGXFUINLZAP-UHFFFAOYSA-N 0.000 description 1
VWAKGGZGYOYTAU-UHFFFAOYSA-N NC(c1cnc(-c2c[nH]c(nc3)c2nc3Cl)nc1NC1(CC1)c(cc1)ccc1F)=O Chemical compound NC(c1cnc(-c2c[nH]c(nc3)c2nc3Cl)nc1NC1(CC1)c(cc1)ccc1F)=O VWAKGGZGYOYTAU-UHFFFAOYSA-N 0.000 description 1
QTKSBOWJUUENDR-UHFFFAOYSA-N NC(c1nc(-c2c[nH]c(N=C3)c2NC3Cl)nc(NC2(CC2)c(cc2)ccc2F)c1)=O Chemical compound NC(c1nc(-c2c[nH]c(N=C3)c2NC3Cl)nc(NC2(CC2)c(cc2)ccc2F)c1)=O QTKSBOWJUUENDR-UHFFFAOYSA-N 0.000 description 1
JZDJCPUJSHPOJP-UHFFFAOYSA-N NC1(CC1)c(cc1)ccc1F Chemical compound NC1(CC1)c(cc1)ccc1F JZDJCPUJSHPOJP-UHFFFAOYSA-N 0.000 description 1
238000005481 NMR spectroscopy Methods 0.000 description 1
229910002651 NO3 Inorganic materials 0.000 description 1
UGJPRRWMGNTRBG-OGLMXYFKSA-N Nc([nH]cc1-c([n]c2)nc(NC3(CC3)c(cc3)ccc3F)c2F)c1/N=C(\C1CC1)/Cl Chemical compound Nc([nH]cc1-c([n]c2)nc(NC3(CC3)c(cc3)ccc3F)c2F)c1/N=C(\C1CC1)/Cl UGJPRRWMGNTRBG-OGLMXYFKSA-N 0.000 description 1
UEMKDDIWJCMVIK-DIBXZPPDSA-N Nc([nH]cc1-c2ccc(C(O)=O)c(NC3(CC3)c(cc3)ccc3F)n2)c1/N=C(/Cl)\I Chemical compound Nc([nH]cc1-c2ccc(C(O)=O)c(NC3(CC3)c(cc3)ccc3F)n2)c1/N=C(/Cl)\I UEMKDDIWJCMVIK-DIBXZPPDSA-N 0.000 description 1
FIJJNTPXRPCBLL-JCMHNJIXSA-N Nc([nH]cc1C(C=CC2)=NC2(NC2CCCCC2)F)c1/N=C(/Cl)\I Chemical compound Nc([nH]cc1C(C=CC2)=NC2(NC2CCCCC2)F)c1/N=C(/Cl)\I FIJJNTPXRPCBLL-JCMHNJIXSA-N 0.000 description 1
AQGZEZAESCKWRR-KALUYTGESA-N Nc(c(-c(nc(cc1)NC2(CC2)c(cc2)ccc2F)c1F)c[nH]1)c1/N=C\[IH]Cl Chemical compound Nc(c(-c(nc(cc1)NC2(CC2)c(cc2)ccc2F)c1F)c[nH]1)c1/N=C\[IH]Cl AQGZEZAESCKWRR-KALUYTGESA-N 0.000 description 1
XXVWEFMTQVZNEM-MXAYSNPKSA-N Nc(c(-c1cccc(NC2(CC2)c2ccccc2)c1)c[nH]1)c1/N=C\[IH]Br Chemical compound Nc(c(-c1cccc(NC2(CC2)c2ccccc2)c1)c[nH]1)c1/N=C\[IH]Br XXVWEFMTQVZNEM-MXAYSNPKSA-N 0.000 description 1
OYBJOCMCVUOGRQ-UKWGHVSLSA-N Nc(c(-c1cccc(NC2CCCC2)n1)c[nH]1)c1/N=C\[IH]Cl Chemical compound Nc(c(-c1cccc(NC2CCCC2)n1)c[nH]1)c1/N=C\[IH]Cl OYBJOCMCVUOGRQ-UKWGHVSLSA-N 0.000 description 1
UTLCAHYZDVRGAD-UHFFFAOYSA-N Nc(c(C(c(cc1NC2(CC2)c2ccccc2)cnc1F)=N)n1)ncc1Cl Chemical compound Nc(c(C(c(cc1NC2(CC2)c2ccccc2)cnc1F)=N)n1)ncc1Cl UTLCAHYZDVRGAD-UHFFFAOYSA-N 0.000 description 1
POTHEILGPJVJQA-UHFFFAOYSA-N Nc(nc12)cnc1[nH]cc2-c1cccc(NC2(CC2)c2ccccc2)c1 Chemical compound Nc(nc12)cnc1[nH]cc2-c1cccc(NC2(CC2)c2ccccc2)c1 POTHEILGPJVJQA-UHFFFAOYSA-N 0.000 description 1
HKKTWERTUZRZAF-UHFFFAOYSA-N Nc1cccc(-c(c2n3)c[nH]c2ncc3Cl)n1 Chemical compound Nc1cccc(-c(c2n3)c[nH]c2ncc3Cl)n1 HKKTWERTUZRZAF-UHFFFAOYSA-N 0.000 description 1
208000012902 Nervous system disease Diseases 0.000 description 1
208000025966 Neurological disease Diseases 0.000 description 1
PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
PEEHTFAAVSWFBL-UHFFFAOYSA-N O=C(C=C1)NC1=O Chemical compound O=C(C=C1)NC1=O PEEHTFAAVSWFBL-UHFFFAOYSA-N 0.000 description 1
QQLSAPCBCVKUSM-UHFFFAOYSA-N O=C(c1cccnc1)Nc1nc(-c2c[nH]c([nH]3)c2nc3Cl)ccc1 Chemical compound O=C(c1cccnc1)Nc1nc(-c2c[nH]c([nH]3)c2nc3Cl)ccc1 QQLSAPCBCVKUSM-UHFFFAOYSA-N 0.000 description 1
SMFIPYSRFMAQLF-UHFFFAOYSA-N O=Cc1cc(NC2(CC2)c(cc2)ccc2F)nc(-c(c2n3)c[nH]c2ncc3Cl)n1 Chemical compound O=Cc1cc(NC2(CC2)c(cc2)ccc2F)nc(-c(c2n3)c[nH]c2ncc3Cl)n1 SMFIPYSRFMAQLF-UHFFFAOYSA-N 0.000 description 1
MFAJXUWFEXMXIY-UHFFFAOYSA-N O=Cc1cc(NC2(CC2)c(cc2)ccc2F)nc(C2=CNC3N=CC(Cl)=NC23)n1 Chemical compound O=Cc1cc(NC2(CC2)c(cc2)ccc2F)nc(C2=CNC3N=CC(Cl)=NC23)n1 MFAJXUWFEXMXIY-UHFFFAOYSA-N 0.000 description 1
SIHFKFQJYGGOEQ-UHFFFAOYSA-N O=S(Cc1ccccc1)(Nc1nc(-c2n[nH]c(NC3)c2N=C3Cl)ncc1)=O Chemical compound O=S(Cc1ccccc1)(Nc1nc(-c2n[nH]c(NC3)c2N=C3Cl)ncc1)=O SIHFKFQJYGGOEQ-UHFFFAOYSA-N 0.000 description 1
YVLNRIAOMOOICE-UHFFFAOYSA-N OC(c(c[n+](Cc1c[nH]c(nc2)c1nc2Cl)[n-]1)c1NC1(CC1)c(cc1)ccc1F)=O Chemical compound OC(c(c[n+](Cc1c[nH]c(nc2)c1nc2Cl)[n-]1)c1NC1(CC1)c(cc1)ccc1F)=O YVLNRIAOMOOICE-UHFFFAOYSA-N 0.000 description 1
HAPZJQKPSWLURL-UHFFFAOYSA-N OCCNc1nc(-c(c2n3)c[nH]c2ncc3Cl)ccc1 Chemical compound OCCNc1nc(-c(c2n3)c[nH]c2ncc3Cl)ccc1 HAPZJQKPSWLURL-UHFFFAOYSA-N 0.000 description 1
SPWJTMCPSXTURQ-UHFFFAOYSA-N OCCNc1nc(-c2c[nH]c([nH]3)c2nc3Cl)ccc1 Chemical compound OCCNc1nc(-c2c[nH]c([nH]3)c2nc3Cl)ccc1 SPWJTMCPSXTURQ-UHFFFAOYSA-N 0.000 description 1
KIOITTCWWWHXMA-UHFFFAOYSA-N OCc1cc(NC2(CC2)C2C=CC(F)=CC2)nc(-c(c2n3)c[nH]c2ncc3Cl)n1 Chemical compound OCc1cc(NC2(CC2)C2C=CC(F)=CC2)nc(-c(c2n3)c[nH]c2ncc3Cl)n1 KIOITTCWWWHXMA-UHFFFAOYSA-N 0.000 description 1
PUHQLXSPXSJFKJ-UHFFFAOYSA-N Oc1cc(C2(CC2)Nc2nc(-c3c[nH]c(N=C4)c3NC4Cl)ncc2F)ccc1 Chemical compound Oc1cc(C2(CC2)Nc2nc(-c3c[nH]c(N=C4)c3NC4Cl)ncc2F)ccc1 PUHQLXSPXSJFKJ-UHFFFAOYSA-N 0.000 description 1
239000005642 Oleic acid Substances 0.000 description 1
ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
208000001132 Osteoporosis Diseases 0.000 description 1
206010061328 Ovarian epithelial cancer Diseases 0.000 description 1
229920002230 Pectic acid Polymers 0.000 description 1
PCNDJXKNXGMECE-UHFFFAOYSA-N Phenazine Natural products C1=CC=CC2=NC3=CC=CC=C3N=C21 PCNDJXKNXGMECE-UHFFFAOYSA-N 0.000 description 1
229920001214 Polysorbate 60 Polymers 0.000 description 1
XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
102000007327 Protamines Human genes 0.000 description 1
108010007568 Protamines Proteins 0.000 description 1
YZCKVEUIGOORGS-IGMARMGPSA-N Protium Chemical compound [1H] YZCKVEUIGOORGS-IGMARMGPSA-N 0.000 description 1
102000013009 Pyruvate Kinase Human genes 0.000 description 1
108020005115 Pyruvate Kinase Proteins 0.000 description 1
235000019485 Safflower oil Nutrition 0.000 description 1
206010039491 Sarcoma Diseases 0.000 description 1
201000010208 Seminoma Diseases 0.000 description 1
102100028904 Serine/threonine-protein kinase MARK2 Human genes 0.000 description 1
206010041067 Small cell lung cancer Diseases 0.000 description 1
108020004459 Small interfering RNA Proteins 0.000 description 1
KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 1
229920002472 Starch Polymers 0.000 description 1
208000006011 Stroke Diseases 0.000 description 1
KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
229930006000 Sucrose Natural products 0.000 description 1
CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
230000006044 T cell activation Effects 0.000 description 1
FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
ZMZDMBWJUHKJPS-UHFFFAOYSA-M Thiocyanate anion Chemical compound [S-]C#N ZMZDMBWJUHKJPS-UHFFFAOYSA-M 0.000 description 1
108090000190 Thrombin Proteins 0.000 description 1
229920001615 Tragacanth Polymers 0.000 description 1
YZCKVEUIGOORGS-NJFSPNSNSA-N Tritium Chemical compound [3H] YZCKVEUIGOORGS-NJFSPNSNSA-N 0.000 description 1
238000006887 Ullmann reaction Methods 0.000 description 1
238000005874 Vilsmeier-Haack formylation reaction Methods 0.000 description 1
239000001089 [(2R)-oxolan-2-yl]methanol Substances 0.000 description 1
LNUFLCYMSVYYNW-ZPJMAFJPSA-N [(2r,3r,4s,5r,6r)-2-[(2r,3r,4s,5r,6r)-6-[(2r,3r,4s,5r,6r)-6-[(2r,3r,4s,5r,6r)-6-[[(3s,5s,8r,9s,10s,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-3-yl]oxy]-4,5-disulfo Chemical compound O([C@@H]1[C@@H](COS(O)(=O)=O)O[C@@H]([C@@H]([C@H]1OS(O)(=O)=O)OS(O)(=O)=O)O[C@@H]1[C@@H](COS(O)(=O)=O)O[C@@H]([C@@H]([C@H]1OS(O)(=O)=O)OS(O)(=O)=O)O[C@@H]1[C@@H](COS(O)(=O)=O)O[C@H]([C@@H]([C@H]1OS(O)(=O)=O)OS(O)(=O)=O)O[C@@H]1C[C@@H]2CC[C@H]3[C@@H]4CC[C@@H]([C@]4(CC[C@@H]3[C@@]2(C)CC1)C)[C@H](C)CCCC(C)C)[C@H]1O[C@H](COS(O)(=O)=O)[C@@H](OS(O)(=O)=O)[C@H](OS(O)(=O)=O)[C@H]1OS(O)(=O)=O LNUFLCYMSVYYNW-ZPJMAFJPSA-N 0.000 description 1
SZPWXAOBLNYOHY-UHFFFAOYSA-N [C]1=CC=NC2=CC=CC=C12 Chemical group [C]1=CC=NC2=CC=CC=C12 SZPWXAOBLNYOHY-UHFFFAOYSA-N 0.000 description 1
AYYGXWBPNXWVGY-UHFFFAOYSA-N [O-][NH+](Cc1cccc(Cl)c1)c1cccc(-c2c[nH]c(nc3)c2nc3Cl)n1 Chemical compound [O-][NH+](Cc1cccc(Cl)c1)c1cccc(-c2c[nH]c(nc3)c2nc3Cl)n1 AYYGXWBPNXWVGY-UHFFFAOYSA-N 0.000 description 1
229940124532 absorption promoter Drugs 0.000 description 1
238000009825 accumulation Methods 0.000 description 1
150000007513 acids Chemical class 0.000 description 1
125000002015 acyclic group Chemical group 0.000 description 1
230000010933 acylation Effects 0.000 description 1
238000005917 acylation reaction Methods 0.000 description 1
208000009956 adenocarcinoma Diseases 0.000 description 1
WNLRTRBMVRJNCN-UHFFFAOYSA-L adipate(2-) Chemical compound [O-]C(=O)CCCCC([O-])=O WNLRTRBMVRJNCN-UHFFFAOYSA-L 0.000 description 1
239000008272 agar Substances 0.000 description 1
229940072056 alginate Drugs 0.000 description 1
239000000783 alginic acid Substances 0.000 description 1
229960001126 alginic acid Drugs 0.000 description 1
150000004781 alginic acids Chemical class 0.000 description 1
239000003513 alkali Substances 0.000 description 1
150000001340 alkali metals Chemical class 0.000 description 1
150000001342 alkaline earth metals Chemical class 0.000 description 1
150000008055 alkyl aryl sulfonates Chemical class 0.000 description 1
229940045714 alkyl sulfonate alkylating agent Drugs 0.000 description 1
150000008052 alkyl sulfonates Chemical class 0.000 description 1
125000001118 alkylidene group Chemical group 0.000 description 1
125000000304 alkynyl group Chemical group 0.000 description 1
208000026935 allergic disease Diseases 0.000 description 1
230000007815 allergy Effects 0.000 description 1
AEMOLEFTQBMNLQ-BKBMJHBISA-N alpha-D-galacturonic acid Chemical compound O[C@H]1O[C@H](C(O)=O)[C@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-BKBMJHBISA-N 0.000 description 1
AWUCVROLDVIAJX-UHFFFAOYSA-N alpha-glycerophosphate Natural products OCC(O)COP(O)(O)=O AWUCVROLDVIAJX-UHFFFAOYSA-N 0.000 description 1
WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
CEGOLXSVJUTHNZ-UHFFFAOYSA-K aluminium tristearate Chemical compound [Al+3].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CEGOLXSVJUTHNZ-UHFFFAOYSA-K 0.000 description 1
229940063655 aluminum stearate Drugs 0.000 description 1
229940024606 amino acid Drugs 0.000 description 1
125000003277 amino group Chemical group 0.000 description 1
230000003321 amplification Effects 0.000 description 1
208000036878 aneuploidy Diseases 0.000 description 1
229940045988 antineoplastic drug protein kinase inhibitors Drugs 0.000 description 1
239000003963 antioxidant agent Substances 0.000 description 1
239000003443 antiviral agent Substances 0.000 description 1
239000007864 aqueous solution Substances 0.000 description 1
229940009098 aspartate Drugs 0.000 description 1
239000003719 aurora kinase inhibitor Substances 0.000 description 1
239000002585 base Substances 0.000 description 1
235000013871 bee wax Nutrition 0.000 description 1
239000012166 beeswax Substances 0.000 description 1
229940077388 benzenesulfonate Drugs 0.000 description 1
SRSXLGNVWSONIS-UHFFFAOYSA-M benzenesulfonate Chemical compound [O-]S(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-M 0.000 description 1
125000003785 benzimidazolyl group Chemical group N1=C(NC2=C1C=CC=C2)* 0.000 description 1
229940050390 benzoate Drugs 0.000 description 1
125000004618 benzofuryl group Chemical group O1C(=CC2=C1C=CC=C2)* 0.000 description 1
WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 1
125000004196 benzothienyl group Chemical group S1C(=CC2=C1C=CC=C2)* 0.000 description 1
229960002903 benzyl benzoate Drugs 0.000 description 1
KGNDCEVUMONOKF-UGPLYTSKSA-N benzyl n-[(2r)-1-[(2s,4r)-2-[[(2s)-6-amino-1-(1,3-benzoxazol-2-yl)-1,1-dihydroxyhexan-2-yl]carbamoyl]-4-[(4-methylphenyl)methoxy]pyrrolidin-1-yl]-1-oxo-4-phenylbutan-2-yl]carbamate Chemical compound C1=CC(C)=CC=C1CO[C@H]1CN(C(=O)[C@@H](CCC=2C=CC=CC=2)NC(=O)OCC=2C=CC=CC=2)[C@H](C(=O)N[C@@H](CCCCN)C(O)(O)C=2OC3=CC=CC=C3N=2)C1 KGNDCEVUMONOKF-UGPLYTSKSA-N 0.000 description 1
WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
XMIIGOLPHOKFCH-UHFFFAOYSA-N beta-phenylpropanoic acid Natural products OC(=O)CCC1=CC=CC=C1 XMIIGOLPHOKFCH-UHFFFAOYSA-N 0.000 description 1
210000003445 biliary tract Anatomy 0.000 description 1
238000004166 bioassay Methods 0.000 description 1
238000010170 biological method Methods 0.000 description 1
IPWKHHSGDUIRAH-UHFFFAOYSA-N bis(pinacolato)diboron Chemical compound O1C(C)(C)C(C)(C)OB1B1OC(C)(C)C(C)(C)O1 IPWKHHSGDUIRAH-UHFFFAOYSA-N 0.000 description 1
201000001531 bladder carcinoma Diseases 0.000 description 1
229920001400 block copolymer Polymers 0.000 description 1
210000004369 blood Anatomy 0.000 description 1
239000008280 blood Substances 0.000 description 1
210000000988 bone and bone Anatomy 0.000 description 1
210000004556 brain Anatomy 0.000 description 1
230000031709 bromination Effects 0.000 description 1
238000005893 bromination reaction Methods 0.000 description 1
229910052794 bromium Inorganic materials 0.000 description 1
125000001246 bromo group Chemical group Br* 0.000 description 1
235000019437 butane-1,3-diol Nutrition 0.000 description 1
KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
239000011575 calcium Substances 0.000 description 1
229910052791 calcium Inorganic materials 0.000 description 1
235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
150000007942 carboxylates Chemical class 0.000 description 1
239000008112 carboxymethyl-cellulose Substances 0.000 description 1
239000012876 carrier material Substances 0.000 description 1
230000003197 catalytic effect Effects 0.000 description 1
230000022131 cell cycle Effects 0.000 description 1
230000010261 cell growth Effects 0.000 description 1
230000001413 cellular effect Effects 0.000 description 1
229920002301 cellulose acetate Polymers 0.000 description 1
210000003793 centrosome Anatomy 0.000 description 1
210000003679 cervix uteri Anatomy 0.000 description 1
229940081733 cetearyl alcohol Drugs 0.000 description 1
230000008859 change Effects 0.000 description 1
229910052729 chemical element Inorganic materials 0.000 description 1
238000005660 chlorination reaction Methods 0.000 description 1
230000002759 chromosomal effect Effects 0.000 description 1
210000000349 chromosome Anatomy 0.000 description 1
230000024321 chromosome segregation Effects 0.000 description 1
238000000576 coating method Methods 0.000 description 1
239000000084 colloidal system Substances 0.000 description 1
210000001072 colon Anatomy 0.000 description 1
238000010835 comparative analysis Methods 0.000 description 1
229940126086 compound 21 Drugs 0.000 description 1
229940125833 compound 23 Drugs 0.000 description 1
229940125851 compound 27 Drugs 0.000 description 1
229940125878 compound 36 Drugs 0.000 description 1
GBRBMTNGQBKBQE-UHFFFAOYSA-L copper;diiodide Chemical compound I[Cu]I GBRBMTNGQBKBQE-UHFFFAOYSA-L 0.000 description 1
230000008878 coupling Effects 0.000 description 1
238000010168 coupling process Methods 0.000 description 1
239000006071 cream Substances 0.000 description 1
238000006880 cross-coupling reaction Methods 0.000 description 1
125000000392 cycloalkenyl group Chemical group 0.000 description 1
230000021953 cytokinesis Effects 0.000 description 1
239000007933 dermal patch Substances 0.000 description 1
229910052805 deuterium Inorganic materials 0.000 description 1
238000007865 diluting Methods 0.000 description 1
GXGAKHNRMVGRPK-UHFFFAOYSA-N dimagnesium;dioxido-bis[[oxido(oxo)silyl]oxy]silane Chemical compound [Mg+2].[Mg+2].[O-][Si](=O)O[Si]([O-])([O-])O[Si]([O-])=O GXGAKHNRMVGRPK-UHFFFAOYSA-N 0.000 description 1
ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
229910000396 dipotassium phosphate Inorganic materials 0.000 description 1
235000019797 dipotassium phosphate Nutrition 0.000 description 1
BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
MOTZDAYCYVMXPC-UHFFFAOYSA-N dodecyl hydrogen sulfate Chemical compound CCCCCCCCCCCCOS(O)(=O)=O MOTZDAYCYVMXPC-UHFFFAOYSA-N 0.000 description 1
229940043264 dodecyl sulfate Drugs 0.000 description 1
239000003792 electrolyte Substances 0.000 description 1
238000000132 electrospray ionisation Methods 0.000 description 1
230000001804 emulsifying effect Effects 0.000 description 1
239000008387 emulsifying waxe Substances 0.000 description 1
239000007920 enema Substances 0.000 description 1
229940095399 enema Drugs 0.000 description 1
238000005516 engineering process Methods 0.000 description 1
239000003623 enhancer Substances 0.000 description 1
230000002255 enzymatic effect Effects 0.000 description 1
AAKJLRGGTJKAMG-UHFFFAOYSA-N erlotinib Chemical compound C=12C=C(OCCOC)C(OCCOC)=CC2=NC=NC=1NC1=CC=CC(C#C)=C1 AAKJLRGGTJKAMG-UHFFFAOYSA-N 0.000 description 1
210000003238 esophagus Anatomy 0.000 description 1
CCIVGXIOQKPBKL-UHFFFAOYSA-M ethanesulfonate Chemical compound CCS([O-])(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-M 0.000 description 1
BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
229940093499 ethyl acetate Drugs 0.000 description 1
235000019325 ethyl cellulose Nutrition 0.000 description 1
229920001249 ethyl cellulose Polymers 0.000 description 1
LVGKNOAMLMIIKO-QXMHVHEDSA-N ethyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC LVGKNOAMLMIIKO-QXMHVHEDSA-N 0.000 description 1
229940093471 ethyl oleate Drugs 0.000 description 1
238000002474 experimental method Methods 0.000 description 1
235000019197 fats Nutrition 0.000 description 1
210000002950 fibroblast Anatomy 0.000 description 1
229910052731 fluorine Inorganic materials 0.000 description 1
235000003599 food sweetener Nutrition 0.000 description 1
239000003205 fragrance Substances 0.000 description 1
125000000524 functional group Chemical group 0.000 description 1
201000006585 gastric adenocarcinoma Diseases 0.000 description 1
239000008273 gelatin Substances 0.000 description 1
229920000159 gelatin Polymers 0.000 description 1
235000019322 gelatine Nutrition 0.000 description 1
235000011852 gelatine desserts Nutrition 0.000 description 1
230000014509 gene expression Effects 0.000 description 1
229940080856 gleevec Drugs 0.000 description 1
208000005017 glioblastoma Diseases 0.000 description 1
239000008103 glucose Substances 0.000 description 1
229960002449 glycine Drugs 0.000 description 1
210000002768 hair cell Anatomy 0.000 description 1
150000004820 halides Chemical class 0.000 description 1
125000000262 haloalkenyl group Chemical group 0.000 description 1
125000004438 haloalkoxy group Chemical group 0.000 description 1
125000001188 haloalkyl group Chemical group 0.000 description 1
230000003862 health status Effects 0.000 description 1
208000014951 hematologic disease Diseases 0.000 description 1
208000018706 hematopoietic system disease Diseases 0.000 description 1
206010073071 hepatocellular carcinoma Diseases 0.000 description 1
MNWFXJYAOYHMED-UHFFFAOYSA-N heptanoic acid Chemical compound CCCCCCC(O)=O MNWFXJYAOYHMED-UHFFFAOYSA-N 0.000 description 1
FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 1
XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
ZMZDMBWJUHKJPS-UHFFFAOYSA-N hydrogen thiocyanate Natural products SC#N ZMZDMBWJUHKJPS-UHFFFAOYSA-N 0.000 description 1
QAOWNCQODCNURD-UHFFFAOYSA-M hydrogensulfate Chemical compound OS([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-M 0.000 description 1
150000004679 hydroxides Chemical class 0.000 description 1
WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
NPZTUJOABDZTLV-UHFFFAOYSA-N hydroxybenzotriazole Substances O=C1C=CC=C2NNN=C12 NPZTUJOABDZTLV-UHFFFAOYSA-N 0.000 description 1
206010020718 hyperplasia Diseases 0.000 description 1
230000007954 hypoxia Effects 0.000 description 1
YLMAHDNUQAMNNX-UHFFFAOYSA-N imatinib methanesulfonate Chemical compound CS(O)(=O)=O.C1CN(C)CCN1CC1=CC=C(C(=O)NC=2C=C(NC=3N=C(C=CN=3)C=3C=NC=CC=3)C(C)=CC=2)C=C1 YLMAHDNUQAMNNX-UHFFFAOYSA-N 0.000 description 1
125000002962 imidazol-1-yl group Chemical group [*]N1C([H])=NC([H])=C1[H] 0.000 description 1
238000000338 in vitro Methods 0.000 description 1
238000001727 in vivo Methods 0.000 description 1
208000033065 inborn errors of immunity Diseases 0.000 description 1
125000003387 indolinyl group Chemical group N1(CCC2=CC=CC=C12)* 0.000 description 1
238000001802 infusion Methods 0.000 description 1
229940102223 injectable solution Drugs 0.000 description 1
229940102213 injectable suspension Drugs 0.000 description 1
150000007529 inorganic bases Chemical class 0.000 description 1
UEXQBEVWFZKHNB-UHFFFAOYSA-N intermediate 29 Natural products C1=CC(N)=CC=C1NC1=NC=CC=N1 UEXQBEVWFZKHNB-UHFFFAOYSA-N 0.000 description 1
230000031146 intracellular signal transduction Effects 0.000 description 1
206010073095 invasive ductal breast carcinoma Diseases 0.000 description 1
230000026045 iodination Effects 0.000 description 1
238000006192 iodination reaction Methods 0.000 description 1
239000011630 iodine Substances 0.000 description 1
238000005342 ion exchange Methods 0.000 description 1
SUMDYPCJJOFFON-UHFFFAOYSA-N isethionic acid Chemical compound OCCS(O)(=O)=O SUMDYPCJJOFFON-UHFFFAOYSA-N 0.000 description 1
QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
125000002183 isoquinolinyl group Chemical group C1(=NC=CC2=CC=CC=C12)* 0.000 description 1
125000001786 isothiazolyl group Chemical group 0.000 description 1
108010082683 kemptide Proteins 0.000 description 1
208000003849 large cell carcinoma Diseases 0.000 description 1
206010023841 laryngeal neoplasm Diseases 0.000 description 1
201000004962 larynx cancer Diseases 0.000 description 1
CFHGBZLNZZVTAY-UHFFFAOYSA-N lawesson's reagent Chemical compound C1=CC(OC)=CC=C1P1(=S)SP(=S)(C=2C=CC(OC)=CC=2)S1 CFHGBZLNZZVTAY-UHFFFAOYSA-N 0.000 description 1
239000000787 lecithin Substances 0.000 description 1
235000010445 lecithin Nutrition 0.000 description 1
229940067606 lecithin Drugs 0.000 description 1
230000000670 limiting effect Effects 0.000 description 1
238000012417 linear regression Methods 0.000 description 1
229910052744 lithium Inorganic materials 0.000 description 1
210000004185 liver Anatomy 0.000 description 1
201000002250 liver carcinoma Diseases 0.000 description 1
239000006210 lotion Substances 0.000 description 1
210000004072 lung Anatomy 0.000 description 1
201000007275 lymphatic system cancer Diseases 0.000 description 1
210000004698 lymphocyte Anatomy 0.000 description 1
VTHJTEIRLNZDEV-UHFFFAOYSA-L magnesium dihydroxide Chemical compound [OH-].[OH-].[Mg+2] VTHJTEIRLNZDEV-UHFFFAOYSA-L 0.000 description 1
239000000347 magnesium hydroxide Substances 0.000 description 1
229910001862 magnesium hydroxide Inorganic materials 0.000 description 1
239000000391 magnesium silicate Substances 0.000 description 1
235000019793 magnesium trisilicate Nutrition 0.000 description 1
229940099273 magnesium trisilicate Drugs 0.000 description 1
229910000386 magnesium trisilicate Inorganic materials 0.000 description 1
239000011976 maleic acid Substances 0.000 description 1
239000000463 material Substances 0.000 description 1
230000035800 maturation Effects 0.000 description 1
238000005259 measurement Methods 0.000 description 1
239000000155 melt Substances 0.000 description 1
239000012528 membrane Substances 0.000 description 1
239000002184 metal Chemical class 0.000 description 1
229910052751 metal Inorganic materials 0.000 description 1
230000031864 metaphase Effects 0.000 description 1
VNWKTOKETHGBQD-UHFFFAOYSA-N methane Natural products C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 1
239000004530 micro-emulsion Substances 0.000 description 1
235000013336 milk Nutrition 0.000 description 1
239000008267 milk Substances 0.000 description 1
210000004080 milk Anatomy 0.000 description 1
229940042472 mineral oil Drugs 0.000 description 1
230000000394 mitotic effect Effects 0.000 description 1
230000008600 mitotic progression Effects 0.000 description 1
CQDGTJPVBWZJAZ-UHFFFAOYSA-N monoethyl carbonate Chemical compound CCOC(O)=O CQDGTJPVBWZJAZ-UHFFFAOYSA-N 0.000 description 1
125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 description 1
210000000214 mouth Anatomy 0.000 description 1
KVBGVZZKJNLNJU-UHFFFAOYSA-M naphthalene-2-sulfonate Chemical compound C1=CC=CC2=CC(S(=O)(=O)[O-])=CC=C21 KVBGVZZKJNLNJU-UHFFFAOYSA-M 0.000 description 1
239000007922 nasal spray Substances 0.000 description 1
230000000926 neurological effect Effects 0.000 description 1
230000003472 neutralizing effect Effects 0.000 description 1
235000001968 nicotinic acid Nutrition 0.000 description 1
239000011664 nicotinic acid Substances 0.000 description 1
201000001705 nipple carcinoma Diseases 0.000 description 1
150000002823 nitrates Chemical class 0.000 description 1
125000004433 nitrogen atom Chemical group N* 0.000 description 1
231100000344 non-irritating Toxicity 0.000 description 1
238000003199 nucleic acid amplification method Methods 0.000 description 1
GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 1
ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
150000007530 organic bases Chemical class 0.000 description 1
201000008482 osteoarthritis Diseases 0.000 description 1
230000002611 ovarian Effects 0.000 description 1
208000013371 ovarian adenocarcinoma Diseases 0.000 description 1
210000001672 ovary Anatomy 0.000 description 1
201000006588 ovary adenocarcinoma Diseases 0.000 description 1
125000004430 oxygen atom Chemical group O* 0.000 description 1
NFHFRUOZVGFOOS-UHFFFAOYSA-N palladium;triphenylphosphane Chemical compound [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 NFHFRUOZVGFOOS-UHFFFAOYSA-N 0.000 description 1
230000036961 partial effect Effects 0.000 description 1
230000000737 periodic effect Effects 0.000 description 1
150000002978 peroxides Chemical class 0.000 description 1
JRKICGRDRMAZLK-UHFFFAOYSA-L peroxydisulfate Chemical compound [O-]S(=O)(=O)OOS([O-])(=O)=O JRKICGRDRMAZLK-UHFFFAOYSA-L 0.000 description 1
239000000825 pharmaceutical preparation Substances 0.000 description 1
WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
239000008363 phosphate buffer Substances 0.000 description 1
RLOWWWKZYUNIDI-UHFFFAOYSA-N phosphinic chloride Chemical compound ClP=O RLOWWWKZYUNIDI-UHFFFAOYSA-N 0.000 description 1
DTBNBXWJWCWCIK-UHFFFAOYSA-N phosphoenolpyruvic acid Chemical class OC(=O)C(=C)OP(O)(O)=O DTBNBXWJWCWCIK-UHFFFAOYSA-N 0.000 description 1
150000003014 phosphoric acid esters Chemical class 0.000 description 1
239000003757 phosphotransferase inhibitor Substances 0.000 description 1
125000004194 piperazin-1-yl group Chemical group [H]N1C([H])([H])C([H])([H])N(*)C([H])([H])C1([H])[H] 0.000 description 1
229950010765 pivalate Drugs 0.000 description 1
IUGYQRQAERSCNH-UHFFFAOYSA-N pivalic acid Chemical compound CC(C)(C)C(O)=O IUGYQRQAERSCNH-UHFFFAOYSA-N 0.000 description 1
229920000058 polyacrylate Polymers 0.000 description 1
239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 1
235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 1
229920000136 polysorbate Polymers 0.000 description 1
229940113124 polysorbate 60 Drugs 0.000 description 1
239000001267 polyvinylpyrrolidone Substances 0.000 description 1
229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
238000010837 poor prognosis Methods 0.000 description 1
SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 1
TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 1
239000004302 potassium sorbate Substances 0.000 description 1
235000010241 potassium sorbate Nutrition 0.000 description 1
229940069338 potassium sorbate Drugs 0.000 description 1
LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 1
229920001592 potato starch Polymers 0.000 description 1
208000028529 primary immunodeficiency disease Diseases 0.000 description 1
230000008569 process Effects 0.000 description 1
230000001737 promoting effect Effects 0.000 description 1
235000013772 propylene glycol Nutrition 0.000 description 1
125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
229950008679 protamine sulfate Drugs 0.000 description 1
229940121649 protein inhibitor Drugs 0.000 description 1
239000012268 protein inhibitor Substances 0.000 description 1
238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 1
125000000561 purinyl group Chemical group N1=C(N=C2N=CNC2=C1)* 0.000 description 1
XFTQRUTUGRCSGO-UHFFFAOYSA-N pyrazin-2-amine Chemical compound NC1=CN=CC=N1 XFTQRUTUGRCSGO-UHFFFAOYSA-N 0.000 description 1
125000003373 pyrazinyl group Chemical group 0.000 description 1
125000003226 pyrazolyl group Chemical group 0.000 description 1
125000002206 pyridazin-3-yl group Chemical group [H]C1=C([H])C([H])=C(*)N=N1 0.000 description 1
125000002098 pyridazinyl group Chemical group 0.000 description 1
125000000246 pyrimidin-2-yl group Chemical group [H]C1=NC(*)=NC([H])=C1[H] 0.000 description 1
125000004527 pyrimidin-4-yl group Chemical group N1=CN=C(C=C1)* 0.000 description 1
125000004528 pyrimidin-5-yl group Chemical group N1=CN=CC(=C1)* 0.000 description 1
239000002510 pyrogen Substances 0.000 description 1
125000000719 pyrrolidinyl group Chemical group 0.000 description 1
125000001453 quaternary ammonium group Chemical group 0.000 description 1
125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 description 1
238000000163 radioactive labelling Methods 0.000 description 1
238000011084 recovery Methods 0.000 description 1
229940100618 rectal suppository Drugs 0.000 description 1
239000006215 rectal suppository Substances 0.000 description 1
201000010174 renal carcinoma Diseases 0.000 description 1
230000010410 reperfusion Effects 0.000 description 1
206010039073 rheumatoid arthritis Diseases 0.000 description 1
239000003813 safflower oil Substances 0.000 description 1
235000005713 safflower oil Nutrition 0.000 description 1
YGSDEFSMJLZEOE-UHFFFAOYSA-M salicylate Chemical compound OC1=CC=CC=C1C([O-])=O YGSDEFSMJLZEOE-UHFFFAOYSA-M 0.000 description 1
229960001860 salicylate Drugs 0.000 description 1
239000000523 sample Substances 0.000 description 1
238000007127 saponification reaction Methods 0.000 description 1
238000003345 scintillation counting Methods 0.000 description 1
238000005204 segregation Methods 0.000 description 1
238000013207 serial dilution Methods 0.000 description 1
230000019491 signal transduction Effects 0.000 description 1
239000000377 silicon dioxide Substances 0.000 description 1
210000003491 skin Anatomy 0.000 description 1
208000000649 small cell carcinoma Diseases 0.000 description 1
208000000587 small cell lung carcinoma Diseases 0.000 description 1
210000000813 small intestine Anatomy 0.000 description 1
AWUCVROLDVIAJX-GSVOUGTGSA-N sn-glycerol 3-phosphate Chemical compound OC[C@@H](O)COP(O)(O)=O AWUCVROLDVIAJX-GSVOUGTGSA-N 0.000 description 1
239000012312 sodium hydride Substances 0.000 description 1
235000019333 sodium laurylsulphate Nutrition 0.000 description 1
239000004334 sorbic acid Substances 0.000 description 1
235000010199 sorbic acid Nutrition 0.000 description 1
229940075582 sorbic acid Drugs 0.000 description 1
239000001587 sorbitan monostearate Substances 0.000 description 1
235000011076 sorbitan monostearate Nutrition 0.000 description 1
229940035048 sorbitan monostearate Drugs 0.000 description 1
230000003595 spectral effect Effects 0.000 description 1
230000020347 spindle assembly Effects 0.000 description 1
230000024355 spindle assembly checkpoint Effects 0.000 description 1
208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
239000007921 spray Substances 0.000 description 1
206010041823 squamous cell carcinoma Diseases 0.000 description 1
235000019698 starch Nutrition 0.000 description 1
239000007858 starting material Substances 0.000 description 1
239000011550 stock solution Substances 0.000 description 1
239000000126 substance Substances 0.000 description 1
125000003107 substituted aryl group Chemical group 0.000 description 1
238000006467 substitution reaction Methods 0.000 description 1
KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 1
239000005720 sucrose Substances 0.000 description 1
235000000346 sugar Nutrition 0.000 description 1
150000008163 sugars Chemical class 0.000 description 1
150000008054 sulfonate salts Chemical class 0.000 description 1
150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
230000001629 suppression Effects 0.000 description 1
239000004094 surface-active agent Substances 0.000 description 1
238000001308 synthesis method Methods 0.000 description 1
239000006188 syrup Substances 0.000 description 1
235000020357 syrup Nutrition 0.000 description 1
239000003826 tablet Substances 0.000 description 1
239000000454 talc Substances 0.000 description 1
229910052623 talc Inorganic materials 0.000 description 1
229940120982 tarceva Drugs 0.000 description 1
239000011975 tartaric acid Substances 0.000 description 1
235000002906 tartaric acid Nutrition 0.000 description 1
229940095064 tartrate Drugs 0.000 description 1
210000001550 testis Anatomy 0.000 description 1
YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
BSYVTEYKTMYBMK-UHFFFAOYSA-N tetrahydrofurfuryl alcohol Chemical compound OCC1CCCO1 BSYVTEYKTMYBMK-UHFFFAOYSA-N 0.000 description 1
125000003039 tetrahydroisoquinolinyl group Chemical group C1(NCCC2=CC=CC=C12)* 0.000 description 1
125000000147 tetrahydroquinolinyl group Chemical group N1(CCCC2=CC=CC=C12)* 0.000 description 1
125000003831 tetrazolyl group Chemical group 0.000 description 1
229960004072 thrombin Drugs 0.000 description 1
210000001685 thyroid gland Anatomy 0.000 description 1
208000030901 thyroid gland follicular carcinoma Diseases 0.000 description 1
238000004448 titration Methods 0.000 description 1
JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 1
238000011200 topical administration Methods 0.000 description 1
239000012049 topical pharmaceutical composition Substances 0.000 description 1
235000010487 tragacanth Nutrition 0.000 description 1
239000000196 tragacanth Substances 0.000 description 1
229940116362 tragacanth Drugs 0.000 description 1
238000011269 treatment regimen Methods 0.000 description 1
125000001425 triazolyl group Chemical group 0.000 description 1
JLEXUIVKURIPFI-UHFFFAOYSA-N tris phosphate Chemical compound OP(O)(O)=O.OCC(N)(CO)CO JLEXUIVKURIPFI-UHFFFAOYSA-N 0.000 description 1
229910052722 tritium Inorganic materials 0.000 description 1
ZDPHROOEEOARMN-UHFFFAOYSA-N undecanoic acid Chemical compound CCCCCCCCCCC(O)=O ZDPHROOEEOARMN-UHFFFAOYSA-N 0.000 description 1
208000010576 undifferentiated carcinoma Diseases 0.000 description 1
208000010570 urinary bladder carcinoma Diseases 0.000 description 1
235000013311 vegetables Nutrition 0.000 description 1
239000003871 white petrolatum Substances 0.000 description 1
210000002268 wool Anatomy 0.000 description 1
150000003751 zinc Chemical class 0.000 description 1

JP2007543441A 2004-11-22 2005-11-22 プロテインキナーゼの阻害剤として有用なピロロピラジンおよびピラゾロピラジン Pending JP2008520738A (ja)